Autosomal recessive hereditary disorders characterized by congenital SENSORINEURAL HEARING LOSS and RETINITIS PIGMENTOSA. Genetically and symptomatically heterogeneous, clinical classes include type I, type II, and type III. Their severity, age of onset of retinitis pigmentosa and the degree of vestibular dysfunction are variable.
A characteristic symptom complex.
Hereditary, progressive degeneration of the neuroepithelium of the retina characterized by night blindness and progressive contraction of the visual field.
Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
A general term for the complete loss of the ability to hear from both ears.
A general term for the complete or partial loss of the ability to hear from one or both ears.
A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain.
Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.
The presence of apparently similar characters for which the genetic evidence indicates that different genes or different genetic mechanisms are involved in different pedigrees. In clinical settings genetic heterogeneity refers to the presence of a variety of genetic defects which cause the same disease, often due to mutations at different loci on the same gene, a finding common to many human diseases including ALZHEIMER DISEASE; CYSTIC FIBROSIS; LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL; and POLYCYSTIC KIDNEY DISEASES. (Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed; Segen, Dictionary of Modern Medicine, 1992)
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
Mechanosensing organelles of hair cells which respond to fluid motion or fluid pressure changes. They have various functions in many different animals, but are primarily used in hearing.
A family of multisubunit cytoskeletal motor proteins that use the energy of ATP hydrolysis to power a variety of cellular functions. Dyneins fall into two major classes based upon structural and functional criteria.
Sensory cells in the organ of Corti, characterized by their apical stereocilia (hair-like projections). The inner and outer hair cells, as defined by their proximity to the core of spongy bone (the modiolus), change morphologically along the COCHLEA. Towards the cochlear apex, the length of hair cell bodies and their apical STEREOCILIA increase, allowing differential responses to various frequencies of sound.
Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).
Calcium-dependent cell adhesion proteins. They are important in the formation of ADHERENS JUNCTIONS between cells. Cadherins are classified by their distinct immunological and tissue specificities, either by letters (E- for epithelial, N- for neural, and P- for placental cadherins) or by numbers (cadherin-12 or N-cadherin 2 for brain-cadherin). Cadherins promote cell adhesion via a homophilic mechanism as in the construction of tissues and of the whole animal body.
Specialized PHOTOTRANSDUCTION neurons in the vertebrates, such as the RETINAL ROD CELLS and the RETINAL CONE CELLS. Non-visual photoreceptor neurons have been reported in the deep brain, the PINEAL GLAND and organs of the circadian system.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Genes that influence the PHENOTYPE only in the homozygous state.
Biochemical identification of mutational changes in a nucleotide sequence.
The study of hearing and hearing impairment.
The essential part of the hearing organ consists of two labyrinthine compartments: the bony labyrinthine and the membranous labyrinth. The bony labyrinth is a complex of three interconnecting cavities or spaces (COCHLEA; VESTIBULAR LABYRINTH; and SEMICIRCULAR CANALS) in the TEMPORAL BONE. Within the bony labyrinth lies the membranous labyrinth which is a complex of sacs and tubules (COCHLEAR DUCT; SACCULE AND UTRICLE; and SEMICIRCULAR DUCTS) forming a continuous space enclosed by EPITHELIUM and connective tissue. These spaces are filled with LABYRINTHINE FLUIDS of various compositions.
The magnitude of INBREEDING in humans.
'Abnormalities, Multiple' is a broad term referring to the presence of two or more structural or functional anomalies in an individual, which may be genetic or environmental in origin, and can affect various systems and organs of the body.
An individual in which both alleles at a given locus are identical.
A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)
A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. (from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556)
A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.
The part of the inner ear (LABYRINTH) that is concerned with hearing. It forms the anterior part of the labyrinth, as a snail-like structure that is situated almost horizontally anterior to the VESTIBULAR LABYRINTH.
The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME.
A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
A number of tests used to determine if the brain or balance portion of the inner ear are causing dizziness.
A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.
The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
The testing of the acuity of the sense of hearing to determine the thresholds of the lowest intensity levels at which an individual can hear a set of tones. The frequencies between 125 and 8000 Hz are used to test air conduction thresholds and the frequencies between 250 and 4000 Hz are used to test bone conduction thresholds.
I'm sorry for any confusion, but "Louisiana" is not a medical term that has a specific definition in the field of medicine. It is actually a state located in the southern United States, known for its diverse culture, food, music, and history. If you have any questions related to healthcare, medicine, or health conditions, I would be happy to try to help answer those!
The concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. (Cline et al., Dictionary of Visual Science, 4th ed)
A mutation in which a codon is mutated to one directing the incorporation of a different amino acid. This substitution may result in an inactive or unstable product. (From A Dictionary of Genetics, King & Stansfield, 5th ed)
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Recording of electric potentials in the retina after stimulation by light.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.
Any method used for determining the location of and relative distances between genes on a chromosome.
A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
A type of mutation in which a number of NUCLEOTIDES deleted from or inserted into a protein coding sequence is not divisible by three, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the mutation. These mutations may be induced by certain types of MUTAGENS or may occur spontaneously.
The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS.
A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.
Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.
The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX.
An amino acid-specifying codon that has been converted to a stop codon (CODON, TERMINATOR) by mutation. Its occurance is abnormal causing premature termination of protein translation and results in production of truncated and non-functional proteins. A nonsense mutation is one that converts an amino acid-specific codon to a stop codon.
Parliamentary democracy located between France on the northeast and Portugual on the west and bordered by the Atlantic Ocean and the Mediterranean Sea.

Characterization of vestibular dysfunction in the mouse model for Usher syndrome 1F. (1/124)

The deaf-circling Ames waltzer (av) mouse harbors a mutation in the protocadherin 15 (Pcdh15) gene and is a model for inner ear defects associated with Usher syndrome type 1F. Earlier studies showed altered cochlear hair cell morphology in young av mice. In contrast, no structural abnormality consistent with significant vestibular dysfunction in young av mice was observed. Light and scanning electron microscopic studies showed that vestibular hair cells from presumptive null alleles Pcdh15(av-Tg) and Pcdh15(av-3J) are morphologically similar to vestibular sensory cells from control littermates, suggesting that the observed phenotype in these alleles might be a result of a central, rather than peripheral, defect. In the present study, a combination of physiologic and anatomic methods was used to more thoroughly investigate the source of vestibular dysfunction in Ames waltzer mice. Analysis of vestibular evoked potentials and angular vestibulo-ocular reflexes revealed a lack of physiologic response to linear and angular acceleratory stimuli in Pcdh15 mutant mice. Optokinetic reflex function was diminished but still present in the mutant animals, suggesting that the defect is primarily peripheral in nature. These findings indicate that the mutation in Pcdh15 results in either a functional abnormality in the vestibular receptor organs or that the defects are limited to the vestibular nerve. AM1-43 dye uptake has been shown to correlate with normal transduction function in hair cells. Dye uptake was found to be dramatically reduced in Pcdh15 mutants compared to control littermates, suggesting that the mutation affects hair cell function, although structural abnormalities consistent with significant vestibular dysfunction are not apparent by light and scanning electron microscopy in the vestibular neuroepithelia of young animals.  (+info)

Identification of a rat model for usher syndrome type 1B by N-ethyl-N-nitrosourea mutagenesis-driven forward genetics. (2/124)

The rat is the most extensively studied model organism and is broadly used in biomedical research. Current rat disease models are selected from existing strains and their number is thereby limited by the degree of naturally occurring variation or spontaneous mutations. We have used ENU mutagenesis to increase genetic variation in laboratory rats and identified a recessive mutant, named tornado, showing aberrant circling behavior, hyperactivity, and stereotypic head shaking. More detailed analysis revealed profound deafness due to disorganization and degeneration of the organ of Corti that already manifests at the onset of hearing. We set up a single nucleotide polymorphism (SNP)-based mapping strategy to identify the affected gene, revealing strong linkage to the central region of chromosome 1. Candidate gene resequencing identified a point mutation that introduces a premature stopcodon in Myo7a. Mutations in human MYO7A result in Usher syndrome type 1B, a severe autosomal inherited recessive disease that involves deafness and vestibular dysfunction. Here, we present the first characterized rat model for this disease. In addition, we demonstrate proof of principle for the generation and cloning of human disease models in rat using ENU mutagenesis, providing good perspectives for systematic phenotypic screens in the rat.  (+info)

Usher I syndrome: unravelling the mechanisms that underlie the cohesion of the growing hair bundle in inner ear sensory cells. (3/124)

Defects in myosin VIIa, the PDZ-domain-containing protein harmonin, cadherin 23 and protocadherin 15 (two cadherins with large extracellular regions), and the putative scaffolding protein Sans underlie five genetic forms of Usher syndrome type I (USH1), the most frequent cause of hereditary deafness-blindness in humans. All USH1 proteins are localised within growing stereocilia and/or the kinocilium that make up the developing auditory hair bundle, the mechanosensitive structure receptive to sound stimulation. Cadherin 23 has been shown to be a component of fibrous links interconnecting the growing stereocilia as well as the kinocilium and the nearest tall stereocilia. A similar function is anticipated for protocadherin 15. Multiple direct interactions between USH1 proteins have been demonstrated. In particular, harmonin b can bind to the cytoplasmic regions of cadherin 23 and protocadherin 15, and to F-actin, and thus probably anchors these cadherins to the actin filaments filling the stereocilia. Myosin VIIa and Sans are both involved in the sorting and/or targeting of harmonin b to the stereocilia. Together, this suggests that the disorganisation of the hair bundles observed in mice mutants lacking orthologues of USH1 proteins may result from a defect of hair-bundle-link-mediated adhesion forces. Moreover, several recent evidences suggest that some genes defective in Usher type II syndrome also encode interstereocilia links, thus bridging the pathogenic pathways of USH1 and USH2 hearing impairment. Additional functions of USH1 proteins in the inner ear and the retina are evident from other phenotypic abnormalities observed in these mice. In particular, myosin VIIa could act at the interface between microtubule- and actin-based transport.  (+info)

Protocadherin-21 (PCDH21), a candidate gene for human retinal dystrophies. (4/124)

PURPOSE: It has been demonstrated that mice lacking a functional copy of prCAD, the gene encoding protocadherin-21, show progressive photoreceptor degeneration. Therefore we searched for a human retinal phenotype associated with mutations in the orthologous human gene, PCDH21. METHODS: We characterized the genomic organization of human PCDH21 and performed mutation screening in 224 patients with autosomal recessive retinitis pigmentosa, 29 patients with Leber congenital amaurosis, and 26 patients with Usher syndrome type 1. RESULTS: PCDH21 spans 23 kb, consists of 17 exons, and encodes a protein that shows close phylogenetic relationship to cadherin-23 (CDH23), the protein involved in Usher syndrome type 1D. In a total of three unrelated patients, we identified two different heterozygous missense changes (p.A212T and p.P532A), affecting evolutionarily conserved residues, that were not found in 100 unaffected controls. A second mutation allele was not detected. A novel intragenic microsatellite marker was identified. CONCLUSIONS: PCDH21 mutations are not a major cause of the retinal diseases investigated herein, and the corresponding human phenotype remains to be determined. Our data may facilitate future investigations of patients with various (other) forms of inherited retinal dystrophy.  (+info)

Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. (5/124)

Usher syndrome (USH) is the most frequent cause of combined deaf-blindness in man. USH is clinically and genetically heterogeneous with at least 11 chromosomal loci assigned to the three USH types (USH1A-G, USH2A-C, USH3A). Although the different USH types exhibit almost the same phenotype in human, the identified USH genes encode for proteins which belong to very different protein classes and families. We and others recently reported that the scaffold protein harmonin (USH1C-gene product) integrates all identified USH1 molecules in a USH1-protein network. Here, we investigated the relationship between the USH2 molecules and this USH1-protein network. We show a molecular interaction between the scaffold protein harmonin (USH1C) and the USH2A protein, VLGR1 (USH2C) and the candidate for USH2B, NBC3. We pinpoint these interactions to interactions between the PDZ1 domain of harmonin and the PDZ-binding motifs at the C-termini of the USH2 proteins and NBC3. We demonstrate that USH2A, VLGR1 and NBC3 are co-expressed with the USH1-protein harmonin in the synaptic terminals of both retinal photoreceptors and inner ear hair cells. In hair cells, these USH proteins are also localized in the signal uptaking stereocilia. Our data indicate that the USH2 proteins and NBC3 are further partners in the supramolecular USH-protein network in the retina and inner ear which shed new light on the function of USH2 proteins and the entire USH-protein network. These findings provide first evidence for a molecular linkage between the pathophysiology in USH1 and USH2. The organization of USH molecules in a mutual 'interactome' related to the disease can explain the common phenotype in USH.  (+info)

Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells. (6/124)

Usher syndrome type IIa (USH2A) combines moderate to severe congenital hearing impairment and retinitis pigmentosa. It is the most common genetic form of USH. USH2A encodes usherin, which was previously defined as a basement membrane protein. A much larger USH2A transcript predicted to encode a transmembrane (TM) isoform was recently reported. Here, we address the role of TM usherin in the inner ear. Analysis of the usherin alternative transcripts in the murine inner ear revealed the existence of several predicted TM usherin isoforms with modular ectodomains of different lengths. In addition, we identified in the usherin cytoplasmic region a predicted 24 amino acid peptide, derived from a newly defined exon that is predominantly expressed in the inner ear but not in the retina. In mouse and rat inner ears, we show that TM usherin is present at the base of the differentiating stereocilia, which make up the mechanosensitive hair bundles receptive to sound. The usherin immunolabeling is transient in the hair bundles of cochlear hair cells (HCs), but persists in mature hair bundles of vestibular HCs. Several lines of evidence support the involvement of TM usherin in the composition of the ankle links, a subset of filamentous lateral links connecting stereocilia at the base. By co-immunoprecipitation and in vitro binding assays, we establish that the usherin cytodomain can bind to whirlin and harmonin, two PDZ domain-containing proteins that are defective in genetic forms of isolated deafness and USH type I, respectively. These PDZ proteins are suitable to provide the anchoring of interstereocilia lateral links to the F-actin core of stereocilia. Our results strongly suggest that congenital deafness in USH type I and type II shares similar pathogenic mechanisms, i.e. the disruption of hair bundle links-mediated adhesion forces that are essential for the proper organization of growing hair bundles.  (+info)

Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%. (7/124)

BACKGROUND: Usher syndrome, a devastating recessive disorder which combines hearing loss with retinitis pigmentosa, is clinically and genetically heterogeneous. Usher syndrome type 1 (USH1) is the most severe form, characterised by profound congenital hearing loss and vestibular dysfunction. OBJECTIVE: To describe an efficient protocol which has identified the mutated gene in more than 90% of a cohort of patients currently living in France. RESULTS: The five genes currently known to cause USH1 (MYO7A, USH1C, CDH23, PCDH15, and USH1G) were tested for. Disease causing mutations were identified in 31 of the 34 families referred: 17 in MYO7A, 6 in CDH23, 6 in PCDH15, and 2 in USH1C. As mutations in genes other than myosin VIIA form nearly 50% of the total, this shows that a comprehensive approach to sequencing is required. Twenty nine of the 46 identified mutations were novel. In view of the complexity of the genes involved, and to minimise sequencing, a protocol for efficient testing of samples was developed. This includes a preliminary linkage and haplotype analysis to indicate which genes to target. It proved very useful and demonstrated consanguinity in several unsuspected cases. In contrast to CDH23 and PCDH15, where most of the changes are truncating mutations, myosin VIIA has both nonsense and missense mutations. Methods for deciding whether a missense mutation is pathogenic are discussed. CONCLUSIONS: Diagnostic testing for USH1 is feasible with a high rate of detection and can be made more efficient by selecting a candidate gene by preliminary linkage and haplotype analysis.  (+info)

Development of a genotyping microarray for Usher syndrome. (8/124)

BACKGROUND: Usher syndrome, a combination of retinitis pigmentosa (RP) and sensorineural hearing loss with or without vestibular dysfunction, displays a high degree of clinical and genetic heterogeneity. Three clinical subtypes can be distinguished, based on the age of onset and severity of the hearing impairment, and the presence or absence of vestibular abnormalities. Thus far, eight genes have been implicated in the syndrome, together comprising 347 protein-coding exons. METHODS: To improve DNA diagnostics for patients with Usher syndrome, we developed a genotyping microarray based on the arrayed primer extension (APEX) method. Allele-specific oligonucleotides corresponding to all 298 Usher syndrome-associated sequence variants known to date, 76 of which are novel, were arrayed. RESULTS: Approximately half of these variants were validated using original patient DNAs, which yielded an accuracy of >98%. The efficiency of the Usher genotyping microarray was tested using DNAs from 370 unrelated European and American patients with Usher syndrome. Sequence variants were identified in 64/140 (46%) patients with Usher syndrome type I, 45/189 (24%) patients with Usher syndrome type II, 6/21 (29%) patients with Usher syndrome type III and 6/20 (30%) patients with atypical Usher syndrome. The chip also identified two novel sequence variants, c.400C>T (p.R134X) in PCDH15 and c.1606T>C (p.C536S) in USH2A. CONCLUSION: The Usher genotyping microarray is a versatile and affordable screening tool for Usher syndrome. Its efficiency will improve with the addition of novel sequence variants with minimal extra costs, making it a very useful first-pass screening tool.  (+info)

Usher Syndromes are a group of genetic disorders that are characterized by hearing loss and visual impairment due to retinitis pigmentosa. They are the most common cause of deafblindness in developed countries. There are three types of Usher Syndromes (Type 1, Type 2, and Type 3) which differ in the age of onset, severity, and progression of hearing loss and vision loss.

Type 1 Usher Syndrome is the most severe form, with profound deafness present at birth or within the first year of life, and retinitis pigmentosa leading to significant vision loss by the teenage years. Type 2 Usher Syndrome is characterized by moderate to severe hearing loss beginning in childhood and vision loss due to retinitis pigmentosa starting in adolescence or early adulthood. Type 3 Usher Syndrome has progressive hearing loss that begins in adolescence and vision loss due to retinitis pigmentosa starting in the third decade of life.

The diagnosis of Usher Syndromes is based on a combination of clinical examination, audiological evaluation, and genetic testing. There is currently no cure for Usher Syndromes, but various assistive devices and therapies can help manage the symptoms and improve quality of life.

A syndrome, in medical terms, is a set of symptoms that collectively indicate or characterize a disease, disorder, or underlying pathological process. It's essentially a collection of signs and/or symptoms that frequently occur together and can suggest a particular cause or condition, even though the exact physiological mechanisms might not be fully understood.

For example, Down syndrome is characterized by specific physical features, cognitive delays, and other developmental issues resulting from an extra copy of chromosome 21. Similarly, metabolic syndromes like diabetes mellitus type 2 involve a group of risk factors such as obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels that collectively increase the risk of heart disease, stroke, and diabetes.

It's important to note that a syndrome is not a specific diagnosis; rather, it's a pattern of symptoms that can help guide further diagnostic evaluation and management.

Retinitis pigmentosa (RP) is a group of rare, genetic disorders that involve a breakdown and loss of cells in the retina - a light-sensitive tissue located at the back of the eye. The retina converts light into electrical signals which are then sent to the brain and interpreted as visual images.

In RP, the cells that detect light (rods and cones) degenerate more slowly than other cells in the retina, leading to a progressive loss of vision. Symptoms typically begin in childhood with night blindness (difficulty seeing in low light), followed by a gradual narrowing of the visual field (tunnel vision). Over time, this can lead to significant vision loss and even blindness.

The condition is usually inherited and there are several different genes that have been associated with RP. The diagnosis is typically made based on a combination of genetic testing, family history, and clinical examination. Currently, there is no cure for RP, but researchers are actively working to develop new treatments that may help slow or stop the progression of the disease.

Sensorineural hearing loss (SNHL) is a type of hearing impairment that occurs due to damage to the inner ear (cochlea) or to the nerve pathways from the inner ear to the brain. It can be caused by various factors such as aging, exposure to loud noises, genetics, certain medical conditions (like diabetes and heart disease), and ototoxic medications.

SNHL affects the ability of the hair cells in the cochlea to convert sound waves into electrical signals that are sent to the brain via the auditory nerve. As a result, sounds may be perceived as muffled, faint, or distorted, making it difficult to understand speech, especially in noisy environments.

SNHL is typically permanent and cannot be corrected with medication or surgery, but hearing aids or cochlear implants can help improve communication and quality of life for those affected.

Deafness is a hearing loss that is so severe that it results in significant difficulty in understanding or comprehending speech, even when using hearing aids. It can be congenital (present at birth) or acquired later in life due to various causes such as disease, injury, infection, exposure to loud noises, or aging. Deafness can range from mild to profound and may affect one ear (unilateral) or both ears (bilateral). In some cases, deafness may be accompanied by tinnitus, which is the perception of ringing or other sounds in the ears.

Deaf individuals often use American Sign Language (ASL) or other forms of sign language to communicate. Some people with less severe hearing loss may benefit from hearing aids, cochlear implants, or other assistive listening devices. Deafness can have significant social, educational, and vocational implications, and early intervention and appropriate support services are critical for optimal development and outcomes.

Hearing loss is a partial or total inability to hear sounds in one or both ears. It can occur due to damage to the structures of the ear, including the outer ear, middle ear, inner ear, or nerve pathways that transmit sound to the brain. The degree of hearing loss can vary from mild (difficulty hearing soft sounds) to severe (inability to hear even loud sounds). Hearing loss can be temporary or permanent and may be caused by factors such as exposure to loud noises, genetics, aging, infections, trauma, or certain medical conditions. It is important to note that hearing loss can have significant impacts on a person's communication abilities, social interactions, and overall quality of life.

Myosins are a large family of motor proteins that play a crucial role in various cellular processes, including muscle contraction and intracellular transport. They consist of heavy chains, which contain the motor domain responsible for generating force and motion, and light chains, which regulate the activity of the myosin. Based on their structural and functional differences, myosins are classified into over 35 classes, with classes II, V, and VI being the most well-studied.

Class II myosins, also known as conventional myosins, are responsible for muscle contraction in skeletal, cardiac, and smooth muscles. They form filaments called thick filaments, which interact with actin filaments to generate force and movement during muscle contraction.

Class V myosins, also known as unconventional myosins, are involved in intracellular transport and organelle positioning. They have a long tail that can bind to various cargoes, such as vesicles, mitochondria, and nuclei, and a motor domain that moves along actin filaments to transport the cargoes to their destinations.

Class VI myosins are also unconventional myosins involved in intracellular transport and organelle positioning. They have two heads connected by a coiled-coil tail, which can bind to various cargoes. Class VI myosins move along actin filaments in a unique hand-over-hand motion, allowing them to transport their cargoes efficiently.

Overall, myosins are essential for many cellular functions and have been implicated in various diseases, including cardiovascular diseases, neurological disorders, and cancer.

Vestibular diseases are a group of disorders that affect the vestibular system, which is responsible for maintaining balance and spatial orientation. The vestibular system includes the inner ear and parts of the brain that process sensory information related to movement and position.

These diseases can cause symptoms such as vertigo (a spinning sensation), dizziness, imbalance, nausea, and visual disturbances. Examples of vestibular diseases include:

1. Benign paroxysmal positional vertigo (BPPV): a condition in which small crystals in the inner ear become dislodged and cause brief episodes of vertigo triggered by changes in head position.
2. Labyrinthitis: an inner ear infection that can cause sudden onset of vertigo, hearing loss, and tinnitus (ringing in the ears).
3. Vestibular neuronitis: inflammation of the vestibular nerve that causes severe vertigo, nausea, and imbalance but typically spares hearing.
4. Meniere's disease: a disorder characterized by recurrent episodes of vertigo, tinnitus, hearing loss, and a feeling of fullness in the affected ear.
5. Vestibular migraine: a type of migraine that includes vestibular symptoms such as dizziness, imbalance, and disorientation.
6. Superior canal dehiscence syndrome: a condition in which there is a thinning or absence of bone over the superior semicircular canal in the inner ear, leading to vertigo, sound- or pressure-induced dizziness, and hearing loss.
7. Bilateral vestibular hypofunction: reduced function of both vestibular systems, causing chronic imbalance, unsteadiness, and visual disturbances.

Treatment for vestibular diseases varies depending on the specific diagnosis but may include medication, physical therapy, surgery, or a combination of these approaches.

Genetic heterogeneity is a phenomenon in genetics where different genetic variations or mutations in various genes can result in the same or similar phenotypic characteristics, disorders, or diseases. This means that multiple genetic alterations can lead to the same clinical presentation, making it challenging to identify the specific genetic cause based on the observed symptoms alone.

There are two main types of genetic heterogeneity:

1. Allelic heterogeneity: Different mutations in the same gene can cause the same or similar disorders. For example, various mutations in the CFTR gene can lead to cystic fibrosis, a genetic disorder affecting the respiratory and digestive systems.
2. Locus heterogeneity: Mutations in different genes can result in the same or similar disorders. For instance, mutations in several genes, such as BRCA1, BRCA2, and PALB2, are associated with an increased risk of developing breast cancer.

Genetic heterogeneity is essential to consider when diagnosing genetic conditions, evaluating recurrence risks, and providing genetic counseling. It highlights the importance of comprehensive genetic testing and interpretation for accurate diagnosis and appropriate management of genetic disorders.

I must clarify that the term "pedigree" is not typically used in medical definitions. Instead, it is often employed in genetics and breeding, where it refers to the recorded ancestry of an individual or a family, tracing the inheritance of specific traits or diseases. In human genetics, a pedigree can help illustrate the pattern of genetic inheritance in families over multiple generations. However, it is not a medical term with a specific clinical definition.

Stereocilia are hair-like projections found in the inner ear, more specifically in the organ of Corti within the cochlea. They are present on the sensory cells known as hair cells and are involved in hearing by converting sound vibrations into electrical signals that can be transmitted to the brain.

Stereocilia are arranged in rows of graded height, with the tallest ones located near the opening of the cochlea (the base) and the shortest ones closer to the apex. When sound waves reach the inner ear, they cause the fluid within the cochlea to move, which in turn causes stereocilia to bend. This bending action triggers the release of chemical signals that stimulate nerve fibers connected to the hair cells, ultimately transmitting information about the sound to the brain.

Damage or loss of stereocilia can result in hearing impairment or deafness, as seen in various forms of hearing disorders and age-related hearing loss.

Dyneins are a type of motor protein that play an essential role in the movement of cellular components and structures within eukaryotic cells. They are responsible for generating force and motion along microtubules, which are critical components of the cell's cytoskeleton. Dyneins are involved in various cellular processes, including intracellular transport, organelle positioning, and cell division.

There are several types of dyneins, but the two main categories are cytoplasmic dyneins and axonemal dyneins. Cytoplasmic dyneins are responsible for moving various cargoes, such as vesicles, organelles, and mRNA complexes, toward the minus-end of microtubules, which is usually located near the cell center. Axonemal dyneins, on the other hand, are found in cilia and flagella and are responsible for their movement by sliding adjacent microtubules past each other.

Dyneins consist of multiple subunits, including heavy chains, intermediate chains, light-intermediate chains, and light chains. The heavy chains contain the motor domain that binds to microtubules and hydrolyzes ATP to generate force. Dysfunction in dynein proteins has been linked to various human diseases, such as neurodevelopmental disorders, ciliopathies, and cancer.

Auditory hair cells are specialized sensory receptor cells located in the inner ear, more specifically in the organ of Corti within the cochlea. They play a crucial role in hearing by converting sound vibrations into electrical signals that can be interpreted by the brain.

These hair cells have hair-like projections called stereocilia on their apical surface, which are embedded in a gelatinous matrix. When sound waves reach the inner ear, they cause the fluid within the cochlea to move, which in turn causes the stereocilia to bend. This bending motion opens ion channels at the tips of the stereocilia, allowing positively charged ions (such as potassium) to flow into the hair cells and trigger a receptor potential.

The receptor potential then leads to the release of neurotransmitters at the base of the hair cells, which activate afferent nerve fibers that synapse with these cells. The electrical signals generated by this process are transmitted to the brain via the auditory nerve, where they are interpreted as sound.

There are two types of auditory hair cells: inner hair cells and outer hair cells. Inner hair cells are the primary sensory receptors responsible for transmitting information about sound to the brain. They make direct contact with afferent nerve fibers and are more sensitive to mechanical stimulation than outer hair cells.

Outer hair cells, on the other hand, are involved in amplifying and fine-tuning the mechanical response of the inner ear to sound. They have a unique ability to contract and relax in response to electrical signals, which allows them to adjust the stiffness of their stereocilia and enhance the sensitivity of the cochlea to different frequencies.

Damage or loss of auditory hair cells can lead to hearing impairment or deafness, as these cells cannot regenerate spontaneously in mammals. Therefore, understanding the structure and function of hair cells is essential for developing therapies aimed at treating hearing disorders.

Extracellular matrix (ECM) proteins are a group of structural and functional molecules that provide support, organization, and regulation to the cells in tissues and organs. The ECM is composed of a complex network of proteins, glycoproteins, and carbohydrates that are secreted by the cells and deposited outside of them.

ECM proteins can be classified into several categories based on their structure and function, including:

1. Collagens: These are the most abundant ECM proteins and provide strength and stability to tissues. They form fibrils that can withstand high tensile forces.
2. Proteoglycans: These are complex molecules made up of a core protein and one or more glycosaminoglycan (GAG) chains. The GAG chains attract water, making proteoglycans important for maintaining tissue hydration and resilience.
3. Elastin: This is an elastic protein that allows tissues to stretch and recoil, such as in the lungs and blood vessels.
4. Fibronectins: These are large glycoproteins that bind to cells and ECM components, providing adhesion, migration, and signaling functions.
5. Laminins: These are large proteins found in basement membranes, which provide structural support for epithelial and endothelial cells.
6. Tenascins: These are large glycoproteins that modulate cell adhesion and migration, and regulate ECM assembly and remodeling.

Together, these ECM proteins create a microenvironment that influences cell behavior, differentiation, and function. Dysregulation of ECM proteins has been implicated in various diseases, including fibrosis, cancer, and degenerative disorders.

Cadherins are a type of cell adhesion molecule that play a crucial role in the development and maintenance of intercellular junctions. They are transmembrane proteins that mediate calcium-dependent homophilic binding between adjacent cells, meaning that they bind to identical cadherin molecules on neighboring cells.

There are several types of cadherins, including classical cadherins, desmosomal cadherins, and protocadherins, each with distinct functions and localization in tissues. Classical cadherins, also known as type I cadherins, are the most well-studied and are essential for the formation of adherens junctions, which help to maintain cell-to-cell contact and tissue architecture.

Desmosomal cadherins, on the other hand, are critical for the formation and maintenance of desmosomes, which are specialized intercellular junctions that provide mechanical strength and stability to tissues. Protocadherins are a diverse family of cadherin-related proteins that have been implicated in various developmental processes, including neuronal connectivity and tissue patterning.

Mutations in cadherin genes have been associated with several human diseases, including cancer, neurological disorders, and heart defects. Therefore, understanding the structure, function, and regulation of cadherins is essential for elucidating their roles in health and disease.

Photoreceptor cells in vertebrates are specialized types of neurons located in the retina of the eye that are responsible for converting light stimuli into electrical signals. These cells are primarily responsible for the initial process of vision and have two main types: rods and cones.

Rods are more numerous and are responsible for low-light vision or scotopic vision, enabling us to see in dimly lit conditions. They do not contribute to color vision but provide information about the shape and movement of objects.

Cones, on the other hand, are less numerous and are responsible for color vision and high-acuity vision or photopic vision. There are three types of cones, each sensitive to different wavelengths of light: short (S), medium (M), and long (L) wavelengths, which correspond to blue, green, and red, respectively. The combination of signals from these three types of cones allows us to perceive a wide range of colors.

Both rods and cones contain photopigments that consist of a protein called opsin and a light-sensitive chromophore called retinal. When light hits the photopigment, it triggers a series of chemical reactions that ultimately lead to the generation of an electrical signal that is transmitted to the brain via the optic nerve. This process enables us to see and perceive our visual world.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Recessive genes refer to the alleles (versions of a gene) that will only be expressed when an individual has two copies of that particular allele, one inherited from each parent. If an individual inherits one recessive allele and one dominant allele for a particular gene, the dominant allele will be expressed and the recessive allele will have no effect on the individual's phenotype (observable traits).

Recessive genes can still play a role in determining an individual's genetic makeup and can be passed down through generations even if they are not expressed. If two carriers of a recessive gene have children, there is a 25% chance that their offspring will inherit two copies of the recessive allele and exhibit the associated recessive trait.

Examples of genetic disorders caused by recessive genes include cystic fibrosis, sickle cell anemia, and albinism.

DNA Mutational Analysis is a laboratory test used to identify genetic variations or changes (mutations) in the DNA sequence of a gene. This type of analysis can be used to diagnose genetic disorders, predict the risk of developing certain diseases, determine the most effective treatment for cancer, or assess the likelihood of passing on an inherited condition to offspring.

The test involves extracting DNA from a patient's sample (such as blood, saliva, or tissue), amplifying specific regions of interest using polymerase chain reaction (PCR), and then sequencing those regions to determine the precise order of nucleotide bases in the DNA molecule. The resulting sequence is then compared to reference sequences to identify any variations or mutations that may be present.

DNA Mutational Analysis can detect a wide range of genetic changes, including single-nucleotide polymorphisms (SNPs), insertions, deletions, duplications, and rearrangements. The test is often used in conjunction with other diagnostic tests and clinical evaluations to provide a comprehensive assessment of a patient's genetic profile.

It is important to note that not all mutations are pathogenic or associated with disease, and the interpretation of DNA Mutational Analysis results requires careful consideration of the patient's medical history, family history, and other relevant factors.

Audiology is a branch of science that deals with the study of hearing, balance disorders, and related conditions. It involves the assessment, diagnosis, and treatment of hearing and balance problems using various tests, techniques, and devices. Audiologists are healthcare professionals who specialize in this field and provide services such as hearing evaluations, fitting of hearing aids, and counseling for people with hearing loss or tinnitus (ringing in the ears). They also work closely with other medical professionals to manage complex cases and provide rehabilitation services.

The inner ear is the innermost part of the ear that contains the sensory organs for hearing and balance. It consists of a complex system of fluid-filled tubes and sacs called the vestibular system, which is responsible for maintaining balance and spatial orientation, and the cochlea, a spiral-shaped organ that converts sound vibrations into electrical signals that are sent to the brain.

The inner ear is located deep within the temporal bone of the skull and is protected by a bony labyrinth. The vestibular system includes the semicircular canals, which detect rotational movements of the head, and the otolith organs (the saccule and utricle), which detect linear acceleration and gravity.

Damage to the inner ear can result in hearing loss, tinnitus (ringing in the ears), vertigo (a spinning sensation), and balance problems.

Consanguinity is a medical and genetic term that refers to the degree of genetic relationship between two individuals who share common ancestors. Consanguineous relationships exist when people are related by blood, through a common ancestor or siblings who have children together. The closer the relationship between the two individuals, the higher the degree of consanguinity.

The degree of consanguinity is typically expressed as a percentage or fraction, with higher values indicating a closer genetic relationship. For example, first-degree relatives, such as parents and children or full siblings, share approximately 50% of their genes and have a consanguinity coefficient of 0.25 (or 25%).

Consanguinity can increase the risk of certain genetic disorders and birth defects in offspring due to the increased likelihood of sharing harmful recessive genes. The risks depend on the degree of consanguinity, with closer relationships carrying higher risks. It is important for individuals who are planning to have children and have a history of consanguinity to consider genetic counseling and testing to assess their risk of passing on genetic disorders.

'Abnormalities, Multiple' is a broad term that refers to the presence of two or more structural or functional anomalies in an individual. These abnormalities can be present at birth (congenital) or can develop later in life (acquired). They can affect various organs and systems of the body and can vary greatly in severity and impact on a person's health and well-being.

Multiple abnormalities can occur due to genetic factors, environmental influences, or a combination of both. Chromosomal abnormalities, gene mutations, exposure to teratogens (substances that cause birth defects), and maternal infections during pregnancy are some of the common causes of multiple congenital abnormalities.

Examples of multiple congenital abnormalities include Down syndrome, Turner syndrome, and VATER/VACTERL association. Acquired multiple abnormalities can result from conditions such as trauma, infection, degenerative diseases, or cancer.

The medical evaluation and management of individuals with multiple abnormalities depend on the specific abnormalities present and their impact on the individual's health and functioning. A multidisciplinary team of healthcare professionals is often involved in the care of these individuals to address their complex needs.

A homozygote is an individual who has inherited the same allele (version of a gene) from both parents and therefore possesses two identical copies of that allele at a specific genetic locus. This can result in either having two dominant alleles (homozygous dominant) or two recessive alleles (homozygous recessive). In contrast, a heterozygote has inherited different alleles from each parent for a particular gene.

The term "homozygote" is used in genetics to describe the genetic makeup of an individual at a specific locus on their chromosomes. Homozygosity can play a significant role in determining an individual's phenotype (observable traits), as having two identical alleles can strengthen the expression of certain characteristics compared to having just one dominant and one recessive allele.

Down syndrome is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It is characterized by intellectual and developmental disabilities, distinctive facial features, and sometimes physical growth delays and health problems. The condition affects approximately one in every 700 babies born in the United States.

Individuals with Down syndrome have varying degrees of cognitive impairment, ranging from mild to moderate or severe. They may also have delayed development, including late walking and talking, and may require additional support and education services throughout their lives.

People with Down syndrome are at increased risk for certain health conditions, such as congenital heart defects, respiratory infections, hearing loss, vision problems, gastrointestinal issues, and thyroid disorders. However, many individuals with Down syndrome live healthy and fulfilling lives with appropriate medical care and support.

The condition is named after John Langdon Down, an English physician who first described the syndrome in 1866.

Metabolic syndrome, also known as Syndrome X, is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes. It is not a single disease but a group of risk factors that often co-occur. According to the American Heart Association and the National Heart, Lung, and Blood Institute, a person has metabolic syndrome if they have any three of the following five conditions:

1. Abdominal obesity (waist circumference of 40 inches or more in men, and 35 inches or more in women)
2. Triglyceride level of 150 milligrams per deciliter of blood (mg/dL) or greater
3. HDL cholesterol level of less than 40 mg/dL in men or less than 50 mg/dL in women
4. Systolic blood pressure of 130 millimeters of mercury (mmHg) or greater, or diastolic blood pressure of 85 mmHg or greater
5. Fasting glucose level of 100 mg/dL or greater

Metabolic syndrome is thought to be caused by a combination of genetic and lifestyle factors, such as physical inactivity and a diet high in refined carbohydrates and unhealthy fats. Treatment typically involves making lifestyle changes, such as eating a healthy diet, getting regular exercise, and losing weight if necessary. In some cases, medication may also be needed to manage individual components of the syndrome, such as high blood pressure or high cholesterol.

Human chromosome pair 10 refers to a group of genetic materials that are present in every cell of the human body. Chromosomes are thread-like structures that carry our genes and are located in the nucleus of most cells. They come in pairs, with one set inherited from each parent.

Chromosome pair 10 is one of the 22 autosomal chromosome pairs, meaning they contain genes that are not related to sex determination. Each member of chromosome pair 10 is a single, long DNA molecule that contains thousands of genes and other genetic material.

Chromosome pair 10 is responsible for carrying genetic information that influences various traits and functions in the human body. Some of the genes located on chromosome pair 10 are associated with certain medical conditions, such as hereditary breast and ovarian cancer syndrome, neurofibromatosis type 1, and Waardenburg syndrome type 2A.

It's important to note that while chromosomes carry genetic information, not all variations in the DNA sequence will result in a change in phenotype or function. Some variations may have no effect at all, while others may lead to changes in how proteins are made and function, potentially leading to disease or other health issues.

Retinal degeneration is a broad term that refers to the progressive loss of photoreceptor cells (rods and cones) in the retina, which are responsible for converting light into electrical signals that are sent to the brain. This process can lead to vision loss or blindness. There are many different types of retinal degeneration, including age-related macular degeneration, retinitis pigmentosa, and Stargardt's disease, among others. These conditions can have varying causes, such as genetic mutations, environmental factors, or a combination of both. Treatment options vary depending on the specific type and progression of the condition.

The retina is the innermost, light-sensitive layer of tissue in the eye of many vertebrates and some cephalopods. It receives light that has been focused by the cornea and lens, converts it into neural signals, and sends these to the brain via the optic nerve. The retina contains several types of photoreceptor cells including rods (which handle vision in low light) and cones (which are active in bright light and are capable of color vision).

In medical terms, any pathological changes or diseases affecting the retinal structure and function can lead to visual impairment or blindness. Examples include age-related macular degeneration, diabetic retinopathy, retinal detachment, and retinitis pigmentosa among others.

The cochlea is a part of the inner ear that is responsible for hearing. It is a spiral-shaped structure that looks like a snail shell and is filled with fluid. The cochlea contains hair cells, which are specialized sensory cells that convert sound vibrations into electrical signals that are sent to the brain.

The cochlea has three main parts: the vestibular canal, the tympanic canal, and the cochlear duct. Sound waves enter the inner ear and cause the fluid in the cochlea to move, which in turn causes the hair cells to bend. This bending motion stimulates the hair cells to generate electrical signals that are sent to the brain via the auditory nerve.

The brain then interprets these signals as sound, allowing us to hear and understand speech, music, and other sounds in our environment. Damage to the hair cells or other structures in the cochlea can lead to hearing loss or deafness.

Genetic linkage is the phenomenon where two or more genetic loci (locations on a chromosome) tend to be inherited together because they are close to each other on the same chromosome. This occurs during the process of sexual reproduction, where homologous chromosomes pair up and exchange genetic material through a process called crossing over.

The closer two loci are to each other on a chromosome, the lower the probability that they will be separated by a crossover event. As a result, they are more likely to be inherited together and are said to be linked. The degree of linkage between two loci can be measured by their recombination frequency, which is the percentage of meiotic events in which a crossover occurs between them.

Linkage analysis is an important tool in genetic research, as it allows researchers to identify and map genes that are associated with specific traits or diseases. By analyzing patterns of linkage between markers (identifiable DNA sequences) and phenotypes (observable traits), researchers can infer the location of genes that contribute to those traits or diseases on chromosomes.

Human chromosome pair 11 consists of two rod-shaped structures present in the nucleus of each cell in the human body. Each member of the pair is a single chromosome, and together they contain the genetic material that is inherited from both parents. They are located on the eleventh position in the standard karyotype, which is a visual representation of the 23 pairs of human chromosomes.

Chromosome 11 is one of the largest human chromosomes and contains an estimated 135 million base pairs. It contains approximately 1,400 genes that provide instructions for making proteins, as well as many non-coding RNA molecules that play a role in regulating gene expression.

Chromosome 11 is known to contain several important genes and genetic regions associated with various human diseases and conditions. For example, it contains the Wilms' tumor 1 (WT1) gene, which is associated with kidney cancer in children, and the neurofibromatosis type 1 (NF1) gene, which is associated with a genetic disorder that causes benign tumors to grow on nerves throughout the body. Additionally, chromosome 11 contains the region where the ABO blood group genes are located, which determine a person's blood type.

It's worth noting that human chromosomes come in pairs because they contain two copies of each gene, one inherited from the mother and one from the father. This redundancy allows for genetic diversity and provides a backup copy of essential genes, ensuring their proper function and maintaining the stability of the genome.

Vestibular function tests are a series of diagnostic assessments used to determine the functionality and health of the vestibular system, which is responsible for maintaining balance and spatial orientation. These tests typically include:

1. **Caloric Testing:** This test evaluates the response of each ear to stimulation with warm and cold water or air. The resulting responses are recorded and analyzed to assess the function of the horizontal semicircular canals and the vestibular-ocular reflex (VOR).

2. **Rotary Chair Testing:** This test measures how well the vestibular system adapts to different speeds of rotation. The patient sits in a chair that moves in a controlled, consistent manner while their eye movements are recorded.

3. **Videonystagmography (VNG):** This test uses video goggles to record eye movements in response to various stimuli, such as changes in head position, temperature, and visual environment.

4. **Electronystagmography (ENG):** Similar to VNG, this test records eye movements but uses electrodes placed near the eyes instead of video goggles.

5. **Dix-Hallpike Test:** This is a clinical maneuver used to diagnose benign paroxysmal positional vertigo (BPPV). It involves rapidly moving the patient's head from an upright position to a position where their head is hanging off the end of the examination table.

6. **Head Shaking Test:** This test involves shaking the head back and forth for 15-20 seconds and then observing the patient's eye movements for nystagmus (involuntary eye movement).

These tests help diagnose various vestibular disorders, including benign paroxysmal positional vertigo, labyrinthitis, vestibular neuritis, Meniere's disease, and other balance disorders.

Human chromosome pair 1 refers to the first pair of chromosomes in a set of 23 pairs found in the cells of the human body, excluding sex cells (sperm and eggs). Each cell in the human body, except for the gametes, contains 46 chromosomes arranged in 23 pairs. These chromosomes are rod-shaped structures that contain genetic information in the form of DNA.

Chromosome pair 1 is the largest pair, making up about 8% of the total DNA in a cell. Each chromosome in the pair consists of two arms - a shorter p arm and a longer q arm - connected at a centromere. Chromosome 1 carries an estimated 2,000-2,500 genes, which are segments of DNA that contain instructions for making proteins or regulating gene expression.

Defects or mutations in the genes located on chromosome 1 can lead to various genetic disorders and diseases, such as Charcot-Marie-Tooth disease type 1A, Huntington's disease, and certain types of cancer.

Blindness is a condition of complete or near-complete vision loss. It can be caused by various factors such as eye diseases, injuries, or birth defects. Total blindness means that a person cannot see anything at all, while near-complete blindness refers to having only light perception or the ability to perceive the direction of light, but not able to discern shapes or forms. Legal blindness is a term used to define a certain level of visual impairment that qualifies an individual for government assistance and benefits; it usually means best corrected visual acuity of 20/200 or worse in the better eye, or a visual field no greater than 20 degrees in diameter.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

Audiometry is the testing of a person's ability to hear different sounds, pitches, or frequencies. It is typically conducted using an audiometer, a device that emits tones at varying volumes and frequencies. The person being tested wears headphones and indicates when they can hear the tone by pressing a button or raising their hand.

There are two main types of audiometry: pure-tone audiometry and speech audiometry. Pure-tone audiometry measures a person's ability to hear different frequencies at varying volumes, while speech audiometry measures a person's ability to understand spoken words at different volumes and in the presence of background noise.

The results of an audiometry test are typically plotted on an audiogram, which shows the quietest sounds that a person can hear at different frequencies. This information can be used to diagnose hearing loss, determine its cause, and develop a treatment plan.

I'm sorry for any confusion, but "Louisiana" is not a medical term or condition. It is a state located in the southern United States, known for its diverse culture, music, food, and history. If you have any questions about medical conditions or terms, I would be happy to help clarify those for you.

"Fundus Oculi" is a medical term that refers to the back part of the interior of the eye, including the optic disc, macula, fovea, retinal vasculature, and peripheral retina. It is the area where light is focused and then transmitted to the brain via the optic nerve, forming visual images. Examinations of the fundus oculi are crucial for detecting various eye conditions such as diabetic retinopathy, macular degeneration, glaucoma, and other retinal diseases. The examination is typically performed using an ophthalmoscope or a specialized camera called a retinal camera.

A missense mutation is a type of point mutation in which a single nucleotide change results in the substitution of a different amino acid in the protein that is encoded by the affected gene. This occurs when the altered codon (a sequence of three nucleotides that corresponds to a specific amino acid) specifies a different amino acid than the original one. The function and/or stability of the resulting protein may be affected, depending on the type and location of the missense mutation. Missense mutations can have various effects, ranging from benign to severe, depending on the importance of the changed amino acid for the protein's structure or function.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Electroretinography (ERG) is a medical test used to evaluate the functioning of the retina, which is the light-sensitive tissue located at the back of the eye. The test measures the electrical responses of the retina to light stimulation.

During the procedure, a special contact lens or electrode is placed on the surface of the eye to record the electrical activity generated by the retina's light-sensitive cells (rods and cones) and other cells in the retina. The test typically involves presenting different levels of flashes of light to the eye while the electrical responses are recorded.

The resulting ERG waveform provides information about the overall health and function of the retina, including the condition of the photoreceptors, the integrity of the inner retinal layers, and the health of the retinal ganglion cells. This test is often used to diagnose and monitor various retinal disorders, such as retinitis pigmentosa, macular degeneration, and diabetic retinopathy.

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

Exons are the coding regions of DNA that remain in the mature, processed mRNA after the removal of non-coding intronic sequences during RNA splicing. These exons contain the information necessary to encode proteins, as they specify the sequence of amino acids within a polypeptide chain. The arrangement and order of exons can vary between different genes and even between different versions of the same gene (alternative splicing), allowing for the generation of multiple protein isoforms from a single gene. This complexity in exon structure and usage significantly contributes to the diversity and functionality of the proteome.

Chromosome mapping, also known as physical mapping, is the process of determining the location and order of specific genes or genetic markers on a chromosome. This is typically done by using various laboratory techniques to identify landmarks along the chromosome, such as restriction enzyme cutting sites or patterns of DNA sequence repeats. The resulting map provides important information about the organization and structure of the genome, and can be used for a variety of purposes, including identifying the location of genes associated with genetic diseases, studying evolutionary relationships between organisms, and developing genetic markers for use in breeding or forensic applications.

Nephrotic syndrome is a group of symptoms that indicate kidney damage, specifically damage to the glomeruli—the tiny blood vessel clusters in the kidneys that filter waste and excess fluids from the blood. The main features of nephrotic syndrome are:

1. Proteinuria (excess protein in urine): Large amounts of a protein called albumin leak into the urine due to damaged glomeruli, which can't properly filter proteins. This leads to low levels of albumin in the blood, causing fluid buildup and swelling.
2. Hypoalbuminemia (low blood albumin levels): As albumin leaks into the urine, the concentration of albumin in the blood decreases, leading to hypoalbuminemia. This can cause edema (swelling), particularly in the legs, ankles, and feet.
3. Edema (fluid retention and swelling): With low levels of albumin in the blood, fluids move into the surrounding tissues, causing swelling or puffiness. The swelling is most noticeable around the eyes, face, hands, feet, and abdomen.
4. Hyperlipidemia (high lipid/cholesterol levels): The kidneys play a role in regulating lipid metabolism. Damage to the glomeruli can lead to increased lipid production and high cholesterol levels in the blood.

Nephrotic syndrome can result from various underlying kidney diseases, such as minimal change disease, membranous nephropathy, or focal segmental glomerulosclerosis. Treatment depends on the underlying cause and may include medications to control inflammation, manage high blood pressure, and reduce proteinuria. In some cases, dietary modifications and lifestyle changes are also recommended.

A frameshift mutation is a type of genetic mutation that occurs when the addition or deletion of nucleotides in a DNA sequence is not divisible by three. Since DNA is read in groups of three nucleotides (codons), which each specify an amino acid, this can shift the "reading frame," leading to the insertion or deletion of one or more amino acids in the resulting protein. This can cause a protein to be significantly different from the normal protein, often resulting in a nonfunctional protein and potentially causing disease. Frameshift mutations are typically caused by insertions or deletions of nucleotides, but they can also result from more complex genetic rearrangements.

G-protein-coupled receptors (GPCRs) are a family of membrane receptors that play an essential role in cellular signaling and communication. These receptors possess seven transmembrane domains, forming a structure that spans the lipid bilayer of the cell membrane. They are called "G-protein-coupled" because they interact with heterotrimeric G proteins upon activation, which in turn modulate various downstream signaling pathways.

When an extracellular ligand binds to a GPCR, it causes a conformational change in the receptor's structure, leading to the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) on the associated G protein's α subunit. This exchange triggers the dissociation of the G protein into its α and βγ subunits, which then interact with various effector proteins to elicit cellular responses.

There are four main families of GPCRs, classified based on their sequence similarities and downstream signaling pathways:

1. Gq-coupled receptors: These receptors activate phospholipase C (PLC), which leads to the production of inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 induces calcium release from intracellular stores, while DAG activates protein kinase C (PKC).
2. Gs-coupled receptors: These receptors activate adenylyl cyclase, which increases the production of cyclic adenosine monophosphate (cAMP) and subsequently activates protein kinase A (PKA).
3. Gi/o-coupled receptors: These receptors inhibit adenylyl cyclase, reducing cAMP levels and modulating PKA activity. Additionally, they can activate ion channels or regulate other signaling pathways through the βγ subunits.
4. G12/13-coupled receptors: These receptors primarily activate RhoGEFs, which in turn activate RhoA and modulate cytoskeletal organization and cellular motility.

GPCRs are involved in various physiological processes, including neurotransmission, hormone signaling, immune response, and sensory perception. Dysregulation of GPCR function has been implicated in numerous diseases, making them attractive targets for drug development.

Human chromosome pair 3 consists of two rod-shaped structures present in the nucleus of each cell in the human body. Each member of the pair is a single chromosome, and together they contain the genetic material that is inherited from both parents. Chromosomes are made up of DNA, which contains the instructions for the development and function of all living organisms.

Human chromosomes are numbered from 1 to 22, with an additional two sex chromosomes (X and Y) that determine biological sex. Chromosome pair 3 is one of the autosomal pairs, meaning it contains genes that are not related to sex determination. Each member of chromosome pair 3 is identical in size and shape and contains a single long DNA molecule that is coiled tightly around histone proteins to form a compact structure.

Chromosome pair 3 is associated with several genetic disorders, including Waardenburg syndrome, which affects pigmentation and hearing; Marfan syndrome, which affects the connective tissue; and some forms of retinoblastoma, a rare eye cancer that typically affects young children.

Sjögren's syndrome is a chronic autoimmune disorder in which the body's immune system mistakenly attacks its own moisture-producing glands, particularly the tear and salivary glands. This can lead to symptoms such as dry eyes, dry mouth, and dryness in other areas of the body. In some cases, it may also affect other organs, leading to a variety of complications.

There are two types of Sjögren's syndrome: primary and secondary. Primary Sjögren's syndrome occurs when the condition develops on its own, while secondary Sjögren's syndrome occurs when it develops in conjunction with another autoimmune disease, such as rheumatoid arthritis or lupus.

The exact cause of Sjögren's syndrome is not fully understood, but it is believed to involve a combination of genetic and environmental factors. Treatment typically focuses on relieving symptoms and may include artificial tears, saliva substitutes, medications to stimulate saliva production, and immunosuppressive drugs in more severe cases.

A haplotype is a group of genes or DNA sequences that are inherited together from a single parent. It refers to a combination of alleles (variant forms of a gene) that are located on the same chromosome and are usually transmitted as a unit. Haplotypes can be useful in tracing genetic ancestry, understanding the genetic basis of diseases, and developing personalized medical treatments.

In population genetics, haplotypes are often used to study patterns of genetic variation within and between populations. By comparing haplotype frequencies across populations, researchers can infer historical events such as migrations, population expansions, and bottlenecks. Additionally, haplotypes can provide information about the evolutionary history of genes and genomic regions.

In clinical genetics, haplotypes can be used to identify genetic risk factors for diseases or to predict an individual's response to certain medications. For example, specific haplotypes in the HLA gene region have been associated with increased susceptibility to certain autoimmune diseases, while other haplotypes in the CYP450 gene family can affect how individuals metabolize drugs.

Overall, haplotypes provide a powerful tool for understanding the genetic basis of complex traits and diseases, as well as for developing personalized medical treatments based on an individual's genetic makeup.

A nonsense codon is a sequence of three nucleotides in DNA or RNA that does not code for an amino acid. Instead, it signals the end of the protein-coding region of a gene and triggers the termination of translation, the process by which the genetic code is translated into a protein.

In DNA, the nonsense codons are UAA, UAG, and UGA, which are also known as "stop codons." When these codons are encountered during translation, they cause the release of the newly synthesized polypeptide chain from the ribosome, bringing the process of protein synthesis to a halt.

Nonsense mutations are changes in the DNA sequence that result in the appearance of a nonsense codon where an amino acid-coding codon used to be. These types of mutations can lead to premature termination of translation and the production of truncated, nonfunctional proteins, which can cause genetic diseases or contribute to cancer development.

I'm sorry for any confusion, but "Spain" is not a medical term. It is a country located in southwestern Europe. If you have any questions about medical terms or topics, I would be happy to help answer them.

... , also known as Hallgren syndrome, Usher-Hallgren syndrome, retinitis pigmentosa-dysacusis syndrome or dystrophia ... Thirteen other syndromes may exhibit signs similar to Usher syndrome, including Alport syndrome, Alström syndrome, Bardet-Biedl ... People with Usher syndrome represent roughly one-sixth of people with retinitis pigmentosa. Usher syndrome is named after the ... GeneReviews/NCBI/NIH/UW entry on Usher Syndrome Type I GeneReviews/NCBI/NIH/UW entry on Usher Syndrome Type II NCBI Genetic ...
RP combined with deafness (congenital or progressive) is called Usher syndrome. Alport's syndrome is associated with RP and an ... A mutation on the USH2A gene is known to cause 10-15% of a syndromic form of RP known as Usher's Syndrome when inherited in an ... "Usher Syndrome". "Diseases - MM - Types Of Overview". Muscular Dystrophy Association. 2015-12-18. "Bardet-Biedl (Laurence Moon ... RP that is not the result of another disease or part of a wider syndrome). Indications of the RP mutation type can be ...
"Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium". American Journal of Medical Genetics. 50 (1): 32-8. doi: ... GeneReviews/NCBI/NIH/UW entry on Usher Syndrome Type I Overview of all the structural information available in the PDB for ... Mutations in the MYO7A gene cause the Usher syndrome type 1B, a combined deafness/blindness disorder. Affected individuals are ... "Linkage of Usher syndrome type I gene (USH1B) to the long arm of chromosome 11". Genomics. 14 (4): 988-94. doi:10.1016/S0888- ...
"Usher Syndrome Society Board & Staff". Usher Syndrome Society. Retrieved April 2, 2022. Official website Going Deaf and Blind ... Deafblindness due to Usher syndrome, Alexander wrote a memoir in 2014 about coming to terms with her deteriorating sight as ... In 2018 she threw a ceremonial first pitch at a Boston Red Sox game to raise awareness of Usher syndrome. "Rebecca Alexander". ... When she began college, she began experiencing tinnitus, and received a diagnosis of Usher syndrome type III at age twenty. ...
Jonard has Usher syndrome; he is both deaf and visually impaired. He competes against non-deaf judoka. Jonard took part in the ...
Clark has Usher syndrome. He is married to the artist Adrean Clark and they have three sons. Grossmann, Mary Ann (October 25, ...
2005). "Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population". Hum. Genet. 116 (4 ... Usher syndrome type-1G protein is a protein that in humans is encoded by the USH1G gene. This gene encodes a protein that ... "Entrez Gene: USH1G Usher syndrome 1G (autosomal recessive)". Ahmed ZM, Riazuddin S, Riazuddin S, Wilcox ER (2004). "The ... The encoded protein interacts with harmonin, which is associated with Usher syndrome type 1C. This protein plays a role in the ...
Usher's Syndrome is the most frequent cause of hereditary deaf-blindness in humans and can be caused by mutations in either PDZ ... December 2005). "A novel D458V mutation in the SANS PDZ binding motif causes atypical Usher syndrome". Journal of Molecular ... Eudy JD, Sumegi J (October 1999). "Molecular genetics of Usher syndrome". Cellular and Molecular Life Sciences. 56 (3-4): 258- ... January 2005). "Liddle's syndrome caused by a novel mutation in the proline-rich PY motif of the epithelial sodium channel beta ...
It is particularly common among those with Usher's syndrome. It results in deafness from birth followed by loss of vision later ... those with Usher's syndrome often grow up in the Deaf community using ASL, and later transition to TASL. TASL differs from ASL ...
"Entrez Gene: USH2A Usher syndrome 2A (autosomal recessive, mild)". Michalski N, Michel V, Bahloul A, Lefèvre G, Barral J, Yagi ... 2003). "Identification of the mouse and rat orthologs of the gene mutated in Usher syndrome type IIA and the cellular source of ... GeneReviews/NCBI/NIH/UW entry on Usher Syndrome Type II v t e (Articles with short description, Short description matches ... 2001). "Spectrum of mutations in USH2A in British patients with Usher syndrome type II". Exp. Eye Res. 72 (5): 503-9. doi: ...
"Usher Syndrome". NIDCD. 2015-08-18. Retrieved 2021-04-12. "Usher Syndrome". NORD (National Organization for Rare Disorders). ... Usher syndrome is caused by gene mutation. CHARGE syndrome is rare, and caused by a genetic disorder. The acronym comes from ... Usher syndrome is the most common condition that causes both deafness and blindness, accounting for around 50% of hereditary ... 50% of deafblindness is due to Usher syndrome. Deaf and hard of hearing individuals who also have learning disabilities tend to ...
In 1996, Zimmer was diagnosed with Usher's syndrome. She hopes to climb all the Seven Summits, the highest mountains of each of ...
In her mid-20s she was diagnosed with Usher syndrome by an ophthalmologist. The loss of vision meant that she forfeited her ... who has a degenerative disease known as Usher syndrome. Kelly began competing in the PT5 paratriathlon classification in ...
She has Usher Syndrome type 1 legally blind and Profoundly deaf. She had a swimming scholarship from the Australian Institute ... This is a result of Usher syndrome and retinitis pigmentosa. She has a brother involved with the surfing community, and has ...
"Secondary vasoproliferative retinal tumor associated with Usher syndrome type 1". J AAPOS. 13 (1): 97-8. doi:10.1016/j.jaapos. ... Murthy R, Naik MN, Desai S, Honavar SG (2009). "PHACE syndrome associated with congenital oculomotor nerve palsy". Strabismus. ... ushering the new and routine era in minimally invasive lacrimal surgeries". Int Ophthalmol. 33 (2): 203-10. doi:10.1007/s10792- ... "Centurion syndrome: clinical presentation and surgical outcome". Orbit. 28 (5): 269-74. doi:10.3109/01676830902856302. PMID ...
Human echinoderm microtubule-associated protein-like is a strong candidate for the Usher syndrome type 1A gene. Usher syndromes ... 1993). "A gene for Usher syndrome type I (USH1A) maps to chromosome 14q". Genomics. 14 (4): 979-87. doi:10.1016/S0888-7543(05) ... 1999). "Volumetric neuroimaging in Usher syndrome: evidence of global involvement". Am. J. Med. Genet. 79 (1): 1-4. doi:10.1002 ... from the Usher syndrome type 1a locus at 14q32". Genomics. 43 (1): 104-6. doi:10.1006/geno.1997.4779. PMID 9226380. Lepley DM, ...
Usher syndrome type 1 is the most severe form of Usher syndrome. The prevalence of Usher syndrome is approximately 3-6 in ... There are multiple types of Usher syndrome that vary in severity and symptomatology depending on the affected gene. Usher ... "Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the ... March 2003). "Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with ...
Mutations of VlgR1 have been shown to result in Usher's syndrome. Knockouts of Vlgr1 in mice have been shown to phenocopy ... 2004). "Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II". Am. J. Hum. ... GeneReviews/NCBI/NIH/UW entry on Usher Syndrome Type II v t e (Articles with short description, Short description matches ... 2000). "Genetic heterogeneity of Usher syndrome type II: localisation to chromosome 5q". J. Med. Genet. 37 (4): 256-62. doi: ...
March 2005). "Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population". Human Genetics ... GeneReviews/NCBI/NIH/UW entry on Usher Syndrome Type I PDBe-KB provides an overview of all the structure information available ... Mutations in this gene have been associated with hearing loss, which is consistent with its location at the Usher syndrome type ... April 2003). "A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome". The New England Journal of Medicine. ...
Sense also supports people in the UK affected by Usher syndrome. Sense also campaigns for the rights of disabled people to take ... This campaign promoted free online lessons in BSL taught by a teenager living with CHARGE syndrome. In 2021, Sense campaigned ...
Her son, Aaron, suffers from Usher syndrome, which is slowly destroying his sight and hearing. With the help of Dr. Barker, ...
This gene is a potential candidate gene for retinitis pigmentosa and Usher syndrome type II. Alternatively spliced transcript ...
Meyers has Usher syndrome and has been deaf since she was born. Since she was young she has used a cochlear implant, an ...
In 2001 Totleben in fact found he was suffering from usher syndrome. Skinn, Dez (w). "Marvelman - The Mightiest Man in the ... After Warrior #21, Marvelman disappeared from the title partway through the second 'book' "The Red King Syndrome". Skinn would ... "Miracleman #2 - The Red King Syndrome". Grand Comics Database. "Miracleman #3 - Olympus". Grand Comics Database. "Miracleman #4 ... The Red King Syndrome was released two years, featuring a cover by John Bolton and compiling strips from #4-7 & #9-10, omitting ...
2000 Apr:130(4S Suppl):921S-926S.) Usher syndrome Hereditary disease that affects hearing and vision and sometimes balance. ... Landau-Kleffner syndrome Childhood disorder of unknown origin which often extends into adulthood and can be identified by ... Meige syndrome Movement disorder that can involve excessive eye blinking (blepharospasm) with involuntary movements of the jaw ... Velocardiofacial syndrome Inherited disorder characterized by cleft palate (opening in the roof of the mouth), heart defects, ...
Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this novel cadherin- ... Siemens J, Kazmierczak P, Reynolds A, Sticker M, Littlewood-Evans A, Müller U (2002). "The Usher syndrome proteins cadherin 23 ... Siemens J, Kazmierczak P, Reynolds A, Sticker M, Littlewood-Evans A, Müller U (2002). "The Usher syndrome proteins cadherin 23 ... "Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C ...
CHML is localized close to the gene for Usher syndrome type II. CHML (gene) has been shown to interact with RAB1A and RAB5A. ... "An autosomal homologue of the choroideremia gene colocalizes with the Usher syndrome type II locus on the distal part of ... gene at 1q42-qter and mutation analysis in patients with Usher syndrome type II". Genomics. 19 (2): 385-7. doi:10.1006/geno. ...
2002). "Usher Syndrome Type III: Revised Genomic Structure of the USH3 Gene and Identification of Novel Mutations". Am. J. Hum ... 2000). "A sequence-ready map of the Usher syndrome type III critical region on chromosome 3q". Genomics. 63 (3): 409-16. doi: ... 2001). "Mutations in a Novel Gene with Transmembrane Domains Underlie Usher Syndrome Type 3". Am. J. Hum. Genet. 69 (4): 673-84 ... Mutations within this gene have been associated with Usher syndrome type IIIa. Multiple transcript variants encoding distinct ...
Morten was born deaf but with good vision, which has gradually deteriorated due to Usher Syndrome. He is now completely blind ...
"Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3". American Journal of Human Genetics. 69 (4 ... Lujan-Fryns syndrome and FG syndrome, as well as instances of prostate cancer. Mutations in MED12 are associated with uterine ... "The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome". Cell. 113 ... "MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling". Proceedings ...
Usher syndrome, also known as Hallgren syndrome, Usher-Hallgren syndrome, retinitis pigmentosa-dysacusis syndrome or dystrophia ... Thirteen other syndromes may exhibit signs similar to Usher syndrome, including Alport syndrome, Alström syndrome, Bardet-Biedl ... People with Usher syndrome represent roughly one-sixth of people with retinitis pigmentosa. Usher syndrome is named after the ... GeneReviews/NCBI/NIH/UW entry on Usher Syndrome Type I GeneReviews/NCBI/NIH/UW entry on Usher Syndrome Type II NCBI Genetic ...
Usher syndrome is caused by changes to certain genes related to sight, hearing, and balance. Its an inherited genetic disease ... Learn more about Usher syndrome Usher syndrome is caused by changes in genes. Its an inherited genetic disease, which means ... If I have an Usher syndrome gene, will I pass it down to my child? If you have Usher syndrome, youll always pass down 1 ... Learn more about the different types of Usher syndrome You can only get Usher syndrome if you inherit 2 copies of an abnormal ( ...
A protein tied to Usher syndrome has been identified as a likely player in the ears conversion of sound into electrical ... Protein Tied To Usher Syndrome May Be Hearings Missing Link. Date:. June 27, 2006. Source:. NIH/National Institute on ... "Protein Tied To Usher Syndrome May Be Hearings Missing Link." ScienceDaily. www.sciencedaily.com. /. releases. /. 2006. /. ... Protocadherin-15 is a protein made by a gene that causes one form of type 1 Usher syndrome, the most common cause of deaf- ...
Facts about Usher Syndrome (National Eye Institute) Usher Syndrome/Learn More ... Usher Syndrome ... National Eye Institute ... Usher syndrome Usher syndrome is a condition characterized by partial or total hearing loss and vision loss that worsens over ... Usher Syndrome (National Library of Medicine) Usher syndrome is an inherited disease that causes serious hearing loss and ... Usher Syndrome (National Institute on Deafness and Other Communication Disorders) Usher syndrome is the most common condition ...
Are you a genetic carrier for Usher Syndrome? ... Usher syndrome type 3A (USH3A) is rare and is caused by genetic ... Detects the CLRN1 gene variant linked to Usher Syndrome Type 3A. *Linked to Usher syndrome in individuals of Ashkenazi Jewish ... Usher syndrome is an inherited condition that leads to hearing and vision loss that worsens over time. Hearing loss is due to ... Usher syndrome type 3A is caused by genetic variation in the CLRN1 gene, which gives instructions for the clarin 1 protein ...
Ushers syndrome. A family study - ophthalmological and audiological findings]. Download Prime PubMed App to iPhone, iPad, or ... Ushers syndrome type 3 in Finland.. *Ushers syndrome and multiple sclerosis. Review of an individual with Ushers syndrome ... A new clinical classification for Ushers syndrome based on a new subtype of Ushers syndrome type I. ... Genetic research on Ushers syndrome in Spain].. *Polyunsaturated fatty acids are lower in blood lipids of Ushers type I but ...
Usher Syndrome A Condition which affects Hearing and Sight. by Mary Guest, Head of Usher Services at Sense.. What is it ? Usher ... Transmission of Usher syndrome, If a person with Usher marries another with the same syndrome, all their children will be ... The child with Usher syndrome has two recessive genes for the trait and will transmit these genes to their offspring. ... In the Usher syndrome form of the disease the retinal condition tends to be diagnosed later rather than earlier in the life of ...
... (USH) is characterized by hearing impairment, progressive vision loss due to retinitis ... Table 1: Usher syndrome subtypes, genes and proteins. Subtype. Gene locus. Gene symbol. Protein name. Protein function/possible ... Usher 1B. 11q13.5. MYO7A. Myosin VIIa. Actin-based motor protein. Usher 1C. 11q15.1. USH1C. Harmonin. PDZ-domain containing ... Usher 1F. 10q21.1. PCDH15. Protocadherin15. Integral membrane adhesion protein. Usher 1G. 17q24-25. USH1/SANS. Sans. Putative ...
Usher syndrome type III is an autosomal recessive disorder characterized by progressive sensorineural hearing loss, vestibular ... Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations Am J Hum Genet. 2002 ... Usher syndrome type III is an autosomal recessive disorder characterized by progressive sensorineural hearing loss, vestibular ... 1 Center for the Study and Treatment of Usher Syndrome, Boys Town National Research Hospital Omaha, NE, 68131, USA. ...
Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population. Hum Genet. 2005; 116:292-9. [ ... Ushers syndrome based on a new subtype of Ushers syndrome type I. Laryngoscope. 2001; 111:84-6. [PMID: 11192904] ... Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. Am J Med Genet. 1994; 50:32-8. [PMID: 8160750] ... French Usher Syndrome Collaboration. Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the ...
Usher syndrome type III can mimic other types of Usher syndrome. Ann Otol Rhinol Laryngol. 2003; 112:525-30. [PMID: 12834121] ... Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the ... Two novel disease-causing mutations in the CLRN1 gene in patients with Usher syndrome type 3 Gema García-García,1 María J. ... Usher syndrome type 3 is rare except among Finns and Ashkenazi Jews. In fact, most studies show that USH3 represents less than ...
Vincent van Gogh and the Roderick Usher Syndrome September 20, 2015. November 14, 2015. René van Slooten ... Another evident victim of the Roderick Usher Syndrome(who, after all, was one of the first well-described cases), was the ... like in Poes The Fall of the House of Usher, where Roderick Usher suffers from many of the severe and typical problems that ... Due to the gaslight, the Salpêtrière was almost as ill-doomed to its inhabitants als Poes House of Usher! ...
The Usher Syndrome Coalition is proud to be a National Alliance of the HLAA Walk4Hearing, the only nationwide event bringing ... You can choose "Usher Syndrome Coalition" from the dropdown menu and the Usher community will benefit from your walk! ... You can support the Usher Syndrome Coalition in your Walk4Hearing. Find a walk near you in the list to the left. To learn more ... Usher Syndrome Coalition is proud to be a National Alliance of the 2022 Walk4Hearing, the only nationwide event bringing ...
Learn about the signs and symptoms of the hereditary condition Usher syndrome, as well as how to live with the condition. ... diagnosed with Usher syndrome type 1 (USH1) at only four years old. But she has never let her diagnosis with Usher syndrome ... Artist with Usher Syndrome Excited to Register on My Retina Tracker to Drive Retinal Research Artist Dana Simon describes her ... Blind Author with Usher Syndrome Ignites the Literary World At the age of 22, Michael Garrigan received a life-changing ...
ERN-EYE network has created a video to make medical staff aware of how to welcome people with Usher syndrome. ... Press release - Usher Syndrome Guidance for healthcare providers. Video about Dos and Donts!. Usher syndrome is a rare ... The aim? To make medical staff aware of how to welcome people with Usher syndrome and to better meet patients needs in ... Domov>Novice>Zadnje novice>Press release - Usher Syndrome Guidance for healthcare providers ...
Join Usher Syndrome Coalition to raise awareness about Ushers Syndrome Type 3. Put your trust in sign language to connect with ... "Children 0-18 years old with Usher syndrome - Intervention" from the Deafblind International Pre-Conference on Usher Syndrome, ... November 2014: Deafblind International Pre-Conference on Usher Syndrome - Bettina Kastrup Pedersen. ... What is Usher syndrome? * Living with Usher Syndrome * Just for Parents * Welcome ...
"Usher Syndromes" by people in this website by year, and whether "Usher Syndromes" was a major or minor topic of these ... "Usher Syndromes" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... Below are the most recent publications written about "Usher Syndromes" by people in Profiles. ... Below are MeSH descriptors whose meaning is more general than "Usher Syndromes". ...
Usher syndrome. More than 60 mutations in the CDH23 gene can cause Usher syndrome type I, which is characterized by a ... All of the CDH23 gene mutations that cause Usher syndrome appear to eliminate the function of cadherin 23. A lack of this ... Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin- ... Mutation profile of the CDH23 gene in 56 probands with Usher syndrome type I. Hum Mutat. 2008 Jun;29(6):E37-46. doi: 10.1002/ ...
Am J Med Genet 50:32-38, 1994). Patients with Usher syndrome type 3 (USH3 OMIM 276902) are born with normal hearing and vision ... Usher syndrome is a clinically heterogeneous disorder characterized by progressive retinitis pigmentosa (RP) and sensorineural ... Usher Syndrome Type 3 (USH3) is an autosomal recessive disease that is caused by variants in the CLRN1 gene (Joensuu et al. Am ... 2002). "Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations." Am J Hum ...
Some patients with Usher syndrome have a mistake, a mutation in that part of the gene. These hereditary errors cause people to ... Van Wijks research group is already working on the development of a possible treatment for another type of Usher syndrome, ... Genetic patch inhibits blindness in patients with Usher syndrome Leiden-based ProQR expands Radboudumc research further ... namely Usher syndrome type 2C (article in Dutch) (USH2C) using minigenes. The principle of the genetic patch is now also being ...
17837 1st Ave So PMB 2, Normandy Park, WA 98148 ...
Usher syndrome. Usher syndrome is one of the most common types of autosomal recessive syndromic hearing loss and is ... Mohr-Tranebjaerg syndrome (deafness-dystonia-optic atrophy syndrome). Mohr-Tranebjaerg syndrome was first described in a large ... Individuals with progressive hearing loss should be evaluated for Alport syndrome, Pendred syndrome, and Stickler syndrome. ... Usher syndrome affects more than 50% of the deaf-blind in the United States.44 It is of significance to note that the visual ...
Usher syndrome. More than 200 mutations in the MYO7A gene have been identified in people with Usher syndrome type I, which is ... Specifically, MYO7A gene mutations cause a form of the disorder known as Usher syndrome type IB (USH1B), which accounts for ... Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature. 1995 Mar 2;374(6517):60-1. doi: 10.1038/374060a0. ... Natural history and retinal structure in patients with Usher syndrome type 1 owing to MYO7A mutation. Ophthalmology. 2014 Feb; ...
... of people with Usher syndrome. Ninety UK-resident adults with Usher syndrome were recruited through deafblind-related charities ... Usher syndromequality of life researchdepressive symptom levelsSocial Support Rating Scaleloneliness scaleHealth, Clinical and ...
We Are Travel Girls is a global travel community created to inspire, connect, educate and empower female travelers around the world. Founded by Becky van Dijk and Vanessa Rivers in 2016, We Are Travel Girls is my favorite travel blog! I frequently visit the We Are Travel Girls website to seek travel advice and find destination inspiration. I also love to read stories of female travelers in the We Are Travel Girls Ladies We Love interview series. When We Are Travel Girls invited me to shar[...]. ...
Thayer Walker writes that "Bill Barkeley is a 46 year old father of 3 with Usher syndrome, a condition that has left him ...
... usher syndrome usher syndrome type 2 vascular Victoria Arlen Victorias Victory Foundation video video podcast virtual program ... usher syndrome , usher syndrome type 2 , visual impairment , yorkshire , young adults ... Tag: usher syndrome. Spotlight Story Program: Meet Asia-Jorden Alexander-Smith. Even one simple tweet can add such a level of ... bladder pain syndrome blind blindness blog blogger blogging boccia boss boss girl boss lady bracelets brighton British british ...
How is Usher Syndrome Handled? Remedy of Usher syndrome largely is determined by a toddlers general well being, in addition to ... What Causes Usher Syndrome to Develop? Usher syndrome is just not a typical sickness however relatively a genetic dysfunction. ... What are the Totally different Classifications of Usher Syndrome? There are three distinctive courses of Usher syndrome, ... Lets check out understanding Usher syndrome.. Its vital to notice that retinitis pigmentosa is just not distinctive to Usher ...
Usher syndrome is a rare, inherited condition or disorder characterized by total or partial loss of hearing and vision that ... Types of Usher Syndrome. Scientists have categorized Usher syndrome into type 1, type 2, and type 3 Usher syndrome, with type 1 ... Prognosis for Usher Syndrome. Although Usher syndrome has no cure, children with Usher syndrome can still live happy and ... Diagnosis and Testing for Usher Syndrome. The diagnosis of Usher syndrome is based on vision, hearing, and balance tests. Usher ...
Approximately 25,000 Americans have Usher syndrome. Though theres no cure, low vision devices and strategies can enhance ... How is Usher syndrome treated?. There is currently no cure for Usher syndrome or for retinitis pigmentosa (RP). Usher syndrome ... What is usher syndrome? Usher syndrome is a rare genetic disorder that affects both hearing and vision. It causes an eye ... Usher Syndrome and Vision Loss. The number of Americans with Usher syndrome is estimated at approximately 25,000. While there ...
  • There are 3 types of Usher syndrome, and each type causes a different mix of hearing loss, balance issues , and vision problems. (nih.gov)
  • Researchers have identified three major types of Usher syndrome, designated as types I, II, and III. (beds.ac.uk)
  • Patients with Usher syndrome should understand the course of their hearing loss, as each of the 3 types of Usher syndrome has a different prognosis regarding hearing. (medscape.com)
  • Usher syndrome, also known as Hallgren syndrome, Usher-Hallgren syndrome, retinitis pigmentosa-dysacusis syndrome or dystrophia retinae dysacusis syndrome, is a rare genetic disorder caused by a mutation in any one of at least 11 genes resulting in a combination of hearing loss and visual impairment. (wikipedia.org)
  • Usher syndrome is a rare disease that causes deafness or hearing loss and an eye disease called retinitis pigmentosa (RP). (nih.gov)
  • Usher syndrome is an inherited disease that causes serious hearing loss and retinitis pigmentosa , an eye disorder that causes your vision to get worse over time. (nih.gov)
  • developed retinitis pigmentosa (a vision disorder characteristic of Usher syndrome ) later in life. (nih.gov)
  • Usher syndrome is an inherited condition which results in hearing loss and a progressive loss of vision from Retinitis pigmentosa (RP). (deafblind.co.uk)
  • Usher syndrome (USH) is characterized by hearing impairment, progressive vision loss due to retinitis pigmentosa (RP) and, in some cases, by vestibular dysfunction. (institut-vision.org)
  • The disease was later named after Dr Charles Usher, a Scottish ophthalmologist who described in 1914 the hereditary nature of the disorder in 19 cases out of 69 patients with retinitis pigmentosa. (institut-vision.org)
  • Usher syndrome type III is an autosomal recessive disorder characterized by progressive sensorineural hearing loss, vestibular dysfunction, and retinitis pigmentosa. (nih.gov)
  • Usher syndrome (USH) is an autosomal recessive disorder, characterized by bilateral hearing loss and retinitis pigmentosa (RP). (molvis.org)
  • Usher syndrome (USH) is an autosomal recessive disease characterized by the association of hearing loss and visual impairment due to retinitis pigmentosa (RP), with or without vestibular dysfunction. (molvis.org)
  • A menudo diagnosticado en la niñez o adolescencia, el síndrome de Usher es una enfermedad hereditaria que causa una combinación de pérdida de audición y visión de la retinitis pigmentaria. (fightingblindness.org)
  • A few children thought to have DFNB12 have developed the vision disorder retinitis pigmentosa later in life, which is characteristic of Usher syndrome. (medlineplus.gov)
  • Usher syndrome is a clinically heterogeneous disorder characterized by progressive retinitis pigmentosa (RP) and sensorineural hearing impairment, with or without vestibular abnormalities. (preventiongenetics.com)
  • Some researchers have suggested that individuals with DFNB2 may actually have Usher syndrome (described below), because some individuals who were thought to have nonsyndromic hearing loss developed retinitis pigmentosa (a vision disorder characteristic of Usher syndrome) later in life. (medlineplus.gov)
  • However, other individuals diagnosed with DFNB2 never develop retinitis pigmentosa, and recent studies indicate that DFNB2 and Usher syndrome probably result from different mutations in the MYO7A gene. (medlineplus.gov)
  • The gene mutation that causes Usher syndrome often affects the light-sensing cells of the retina, called cones and rods, resulting in a condition termed as retinitis pigmentosa (RP). (topessaywriting.org)
  • Low-vision device may be helpful for you if you have Usher syndrome, particularly retinitis pigmentosa. (amplifyeye.care)
  • Children born with type I of Usher syndrome begin to lose their vision as a result of Retinitis Pigmentosa (RP). (amplifyeye.care)
  • There is currently no cure for Usher syndrome or for retinitis pigmentosa (RP). (amplifyeye.care)
  • It's vital to notice that retinitis pigmentosa is just not distinctive to Usher syndrome however can truly be brought on by a spread of various circumstances. (matkaforfree.com)
  • Vision loss in Usher Syndrome is due to Retinitis Pigmentosa (RP), a degenerative condition of the retina. (notionsndreams.com)
  • Usher Syndrome is a genetic condition that is a combination of being deaf/hard-of-hearing and having an eye disease called Retinitis Pigmentosa. (notionsndreams.com)
  • There is also a disorder resembling Usher that results from homozygous mutations in ABHD12 (20p11.21) that also causes PHARC ( 612674 ) (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early onset cataract). (arizona.edu)
  • The main symptoms of Usher Syndrome are hearing loss and an eye condition called retinitis pigmentosa (RP). (rnib.org.uk)
  • Usher syndrome type III is characterized by postlingual, progressive hearing loss, variable vestibular dysfunction, and onset of retinitis pigmentosa symptoms, including nyctalopia, constriction of the visual fields, and loss of central visual acuity, usually by the second decade of life (Karjalainen et al. (beds.ac.uk)
  • ProQR Therapeutics reported positive results from a planned analysis of its phase 1/2 Stellar trial of QR-421a in adults with Usher syndrome and non-syndromic retinitis pigmentosa due to USH2A exon 13 mutations. (globalgenes.org)
  • Usher syndrome type 2a and non-syndromic retinitis pigmentosa can be caused by mutations in the USH2A gene. (globalgenes.org)
  • QR-421a is a first-in-class investigational RNA therapy designed to address the underlying cause of vision loss in Usher syndrome type 2a and non-syndromic retinitis pigmentosa due to mutations in exon 13 of the USH2A gene. (globalgenes.org)
  • Characteristics of Retinitis Pigmentosa Associated with ADGRV1 and Comparison with USH2A in Patients from a Multicentric Usher Syndrome Study Treatrush. (bvsalud.org)
  • citation needed] Mutations in only one gene, CLRN1, have been linked to Usher syndrome type III. (wikipedia.org)
  • Usher syndrome type 3A (USH3A) is rare and is caused by genetic variation in the CLRN1 gene, which gives information to make the clarin 1 protein. (genebase.com)
  • Usher syndrome type 3A is caused by genetic variation in the CLRN1 gene, which gives instructions for the clarin 1 protein involved in hearing and vision. (genebase.com)
  • This test looks at one genetic variant of the CLRN1 gene linked to Usher Syndrome Type 3A, which becomes apparent later in childhood or adolescence. (genebase.com)
  • To identify the genetic defect in Spanish families with Usher syndrome (USH) and probable involvement of the CLRN1 gene. (molvis.org)
  • Usher Syndrome Type 3 (USH3) is an autosomal recessive disease that is caused by variants in the CLRN1 gene (Joensuu et al. (preventiongenetics.com)
  • Usher syndrome IIIA (USH3A) is an autosomal recessive disorder characterized by progressive loss of hearing and vision due to mutation in the clarin-1 (CLRN1) gene. (grantome.com)
  • Usher syndrome is classed into three subtypes (I, II and III) according to the genes responsible and the onset of deafness. (wikipedia.org)
  • citation needed] Usher syndrome type I can be caused by mutations in any one of several different genes: CDH23, MYO7A, PCDH15, USH1C and USH1G. (wikipedia.org)
  • citation needed] Usher syndrome type II may be caused by mutations in any of three different genes: USH2A, GPR98 and DFNB31. (wikipedia.org)
  • Usher syndrome is caused by changes in genes. (nih.gov)
  • How do genes cause Usher syndrome? (nih.gov)
  • Usher syndrome is caused by changes to certain genes related to sight, hearing, and balance. (nih.gov)
  • Can I get tested for Usher syndrome genes? (nih.gov)
  • Yes, there are genetic tests for the genes that cause Usher syndrome. (nih.gov)
  • The child with Usher syndrome has two recessive genes for the trait and will transmit these genes to their offspring. (deafblind.co.uk)
  • The probability that a child whose both parents have Usher genes will have Usher syndrome is 25 percent (Rogan, 2010). (topessaywriting.org)
  • Usher syndrome is defined by significant genetic heterogeneity, with at least 12 distinct loci described and 9 genes identified. (units.it)
  • One patient was found to be compound heterozygous for mutations in two different genes and this represents an example of possible digenic inheritance in Usher syndrome. (units.it)
  • Conclusions: These findings highlight the efficacy of the APEX-based genotyping approach in the molecular assessment of Usher patients, suggesting the presence of alleles not yet identified and/or the involvement of additional putative genes that may account for the pathogenesis of Usher syndrome. (units.it)
  • The condition is named after a British ophthalmologist, C.H. Usher, who in a paper in 1914 described several cases in which the link between congenital deafness and RP was stressed. (deafblind.co.uk)
  • Additionally of word is the truth that though Usher syndrome is comparatively uncommon in comparison with different congenital points, it's nonetheless the most typical supply of twin listening to and imaginative and prescient loss in kids. (matkaforfree.com)
  • One of these syndromes includes congenital hearing loss as well (Usher syndrome). (msdmanuals.com)
  • Protocadherin-15 is a protein made by a gene that causes one form of type 1 Usher syndrome, the most common cause of deaf-blindness in humans. (sciencedaily.com)
  • Usher syndrome impacts each listening to and sight, with severity starting from gentle impairment to finish deafness and blindness. (matkaforfree.com)
  • It takes a team, including adults with Usher, an education specialist who knows about the combination of hearing and vision loss (deaf-blindness), and educators who recognize that communication/language needs to be a primary focus. (wa.gov)
  • Usher Syndrome Coalition - Their mission is to raise awareness and accelerate research for the most common cause of combined deafness and blindness. (notionsndreams.com)
  • Usher syndrome is the leading cause of combined deafness and blindness. (globalgenes.org)
  • Usher Syndrome type 1F is a rare but severe genetic disease that causes deafness, lack of balance, and progressive blindness. (azolifesciences.com)
  • Because vision loss in Usher 1F involves a slightly different form of the same protein, the researchers say the same approach may be useful for preventing blindness. (azolifesciences.com)
  • More than 60 mutations in the CDH23 gene can cause Usher syndrome type I, which is characterized by a combination of hearing loss, vision loss, and problems with balance and coordination. (medlineplus.gov)
  • Specifically, CDH23 gene mutations cause a form of the disorder known as Usher syndrome type ID (USH1D). (medlineplus.gov)
  • All of the CDH23 gene mutations that cause Usher syndrome appear to eliminate the function of cadherin 23. (medlineplus.gov)
  • More than 200 mutations in the MYO7A gene have been identified in people with Usher syndrome type I, which is characterized by a combination of hearing loss, vision loss, and problems with balance and coordination. (medlineplus.gov)
  • Specifically, MYO7A gene mutations cause a form of the disorder known as Usher syndrome type IB (USH1B), which accounts for more than half of all cases of Usher syndrome type I. (medlineplus.gov)
  • Usher syndrome is an inherited or genetic disorder, which implies that it is passed from parents to children and results from gene mutations. (topessaywriting.org)
  • The hearing loss in Usher syndrome results from the gene mutations that affect the cochlea's nerve cells by interfering with their normal sound transmission. (topessaywriting.org)
  • Methods: Molecular data have been obtained on 75 unrelated Italian patients using the most up-to date technology available for the screening of Usher syndrome gene mutations, i.e., the genotyping microarray developed by Asper Biotech (Tartu, Estonia), which simultaneously investigates 612 different marker positions using the well established arrayed primer extension methodology (APEX). (units.it)
  • A total of 66.6% of cases (50 out of 75) were found to be completely negative for the presence of Usher syndrome gene mutations in the detected positions. (units.it)
  • La pérdida de audición en el síndrome de Usher ocurre porque las mutaciones genéticas que afectan a la retina también afectan a la cóclea, una estructura transmisora de sonido del oído interno. (fightingblindness.org)
  • Be positive when talking to the patient about their disease: talk about changes in vision, emphasise what they will still be able to do, give them examples of positive role models they will be able to identify with, and encourage them to join patient groups such as the Retina and Usher family groups. (ern-eye.eu)
  • Hearing loss due to Usher Syndrome is adversely affected by the same mechanism that causes cells to die in the retina. (notionsndreams.com)
  • Children with Usher Syndrome are typically born completely deaf or with severely impaired hearing, lack balance, and lose vision over time as the retina deteriorates. (azolifesciences.com)
  • cause a form of the condition known as Usher syndrome type IIIA (USH3A). (nih.gov)
  • People affected by USH3A make abnormal clarin 1 protein, leading to Usher syndrome. (genebase.com)
  • 1995). For a discussion of genetic heterogeneity of type III Usher syndrome, see USH3A (276902). (beds.ac.uk)
  • Complete ophthalmic examinations were conducted on two boys and two girls from two related Hutterite families diagnosed with Usher syndrome type I. DNA from patients and their parents was first evaluated for a mutation in exon 10 of the protocadherin-related 15 ( PCDH15 ) gene (c.1471delG), previously reported in southern Alberta Hutterite patients with Usher syndrome (USH1F). (molvis.org)
  • Patients with Usher syndrome type 3 (USH3 OMIM 276902) are born with normal hearing and vision. (preventiongenetics.com)
  • Some patients with Usher syndrome have a mistake, a mutation in that part of the gene. (radboudumc.nl)
  • Patients with Usher 1F are born with profound hearing loss and progressive vision loss, and so far we have been able to offer very few solutions to these families. (azolifesciences.com)
  • Usher syndrome is named after Scottish ophthalmologist Charles Usher, who examined the pathology and transmission of the syndrome in 1914. (wikipedia.org)
  • Usher syndrome is a rare inherited or genetic disorder, characterized by loss of hearing and vision, and named after Charles Usher, the Scottish ophthalmologist who examined the condition's transmission and pathology in 1914 (Ahmed et al. (topessaywriting.org)
  • CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. (medlineplus.gov)
  • According to the National Institutes of Health's recent report, 3 to 6 percent of children with deafness and 3 to 6 percent of children with hearing difficulties have Usher syndrome (Rogan, 2010). (topessaywriting.org)
  • Children with Usher syndrome often born with hearing difficulties or deafness, while the loss of vision usually develops during childhood or adolescence (Ahmed et al. (topessaywriting.org)
  • Using data generated from patients and mice with genetic mutation for the disorder Usher syndrome, researchers from the University of Maryland School of Medicine, the National Institutes of Health's National Eye Institute, and National Institute on Deafness and Other Communication Disorders, documented the natural history of vision impairment in patients and identified the cell mechanism behind progressive vision loss. (news-medical.net)
  • Babies born with type 1 Usher syndrome are almost totally deaf at the time of birth, and they have severe balance problems. (topessaywriting.org)
  • Besides, children with type 1 Usher syndrome are late walkers, and they often have less likelihood of benefitting from hearing aids (Ouyang et al. (topessaywriting.org)
  • Approximately 25,000 people in the United States have some form of Usher syndrome (click on the "More Info" tab to read more about Types I, II and III). (wa.gov)
  • The hearing loss associated with this form of Usher syndrome ranges from mild to severe and mainly affects the ability to hear high-frequency sounds. (beds.ac.uk)
  • In fact, if 2 people with the same abnormal gene Usher syndrome carriers have a child together, that child has only a 1 in 4 chance of having symptoms of Usher syndrome. (nih.gov)
  • If your child has symptoms of Usher syndrome, their doctor may recommend genetic testing to find out for sure. (nih.gov)
  • What are the different signs and symptoms of Usher syndrome? (amplifyeye.care)
  • The symptoms of Usher syndrome vary based on its type. (amplifyeye.care)
  • Educational Accommodations to Consider for Children, Teens, and College Students with Usher Syndrome Tips and strategies about accommodations in school settings. (wa.gov)
  • It is with great pride that we announce the inaugural Usher Syndrome Awareness Day in Washington State, to be observed on September 16th, 2023. (lhblind.org)
  • 14 April 2021 Een kennis- en investeringsconsortium met het Radboudumc heeft acht miljoen euro subsidie gekregen om innovatie op het gebied van Artificial Intelligence (AI) versneld naar de markt te brengen. (radboudumc.nl)
  • The finding of a MYO7A mutation in two related Hutterite families from northern Alberta provides evidence of genetic heterogeneity in Hutterites affected by Usher syndrome type I. (molvis.org)
  • Here, we describe two Hutterite families from northern Alberta with Usher syndrome type I who did not carry a mutation in exon 10 of PCDH15 but did carry a mutation in exon 3 of the myosin VIIA ( MYO7 A) gene, providing evidence of genetic heterogeneity in Alberta Hutterites with Usher syndrome type I. (molvis.org)
  • Usher syndrome is described as an autosomal recessive disorder, which means that it can affect both males and females (Williams, 2008). (topessaywriting.org)
  • Purpose: Usher syndrome is an autosomal recessive disorder characterized by hearing and vision loss. (units.it)
  • Usher is transmitted genetically by an autosomal recessive gene. (deafblind.co.uk)
  • citation needed] The frequency of Usher syndrome type III is significant only in the Finnish population as well as the population of Birmingham, UK, and individuals of Ashkenazi Jewish heritage. (wikipedia.org)
  • Las personas con el síndrome de Usher tipo 1 (USH1) usualmente nacen con una grave pérdida auditiva y experimentan problemas con el equilibrio. (fightingblindness.org)
  • Por ejemplo, las personas con síndrome de Usher tipo 1B tienen mutaciones en el gen MYO7A. (fightingblindness.org)
  • Usher Syndrome Awareness Day Declared in Washington State! (lhblind.org)
  • Governor Inslee signed the proclamation, officially designating the third Saturday in September as Usher Syndrome Awareness Day. (lhblind.org)
  • This type of Usher syndrome also causes abnormalities of the vestibular system, which is the part of the inner ear that helps maintain the body's balance and orientation in space. (beds.ac.uk)
  • A protein tied to Usher syndrome has been identified as a likely player in the ear's conversion of sound into electrical signals. (sciencedaily.com)
  • A child who is identified as being at high risk for Usher syndrome should be referred immediately to an ophthalmological clinic which has the capacity for full diagnostic testing. (deafblind.co.uk)
  • Pakarinen L, Tuppurainen K, Laippala P, M?SSntyj?SSrvi M, Puhakka H. The ophthalmological course of Usher syndrome type III . (arizona.edu)
  • People with Usher I are born profoundly deaf and begin to lose their vision in the first decade of life. (wikipedia.org)
  • citation needed] Worldwide, the estimated prevalence of Usher syndrome type I is 3 to 6 per 100,000 people in the general population. (wikipedia.org)
  • citation needed] Usher syndrome type II occurs at least as frequently as type I, but because type II may be underdiagnosed or more difficult to detect, it could be up to three times as common as type I.[citation needed] People with Usher syndrome III are not born deaf but experience a progressive loss of hearing, and roughly half have balance difficulties. (wikipedia.org)
  • One of the earliest descriptions of this syndrome was given by Dr Albrecht von Graefe who identified the disease among Jewish people in Berlin in 1858. (institut-vision.org)
  • Usher syndrome is a rare genetic disease that affects approximately one in 30,000 people. (ern-eye.eu)
  • To make medical staff aware of how to welcome people with Usher syndrome and to better meet patients' needs in clinical settings. (ern-eye.eu)
  • This is the kind of advice the video gives to health professionals on how to deal with people with Usher syndrome in a medical environment. (ern-eye.eu)
  • This graph shows the total number of publications written about "Usher Syndromes" by people in this website by year, and whether "Usher Syndromes" was a major or minor topic of these publications. (wakehealth.edu)
  • Below are the most recent publications written about "Usher Syndromes" by people in Profiles. (wakehealth.edu)
  • The aim of this study was to determine if psychosocial wellbeing predicts the health-related quality of life (HRQOL) of people with Usher syndrome. (figshare.com)
  • Learn more about people who grew up with Usher syndrome. (wa.gov)
  • With an estimated 50,000 people with Usher Syndrome in the US alone, it is considered the leading cause of combined deaf/blind disorders worldwide. (notionsndreams.com)
  • Cosgrove and De Vlaminck will look for gene activity in muscle fibers, blood vessels and immune cells from the biopsies of ME/CFS patients and controls to see what differences are found in people with the syndrome. (asbmb.org)
  • A new film by RNIB aims to help people understand how Usher Syndrome can affect children. (rnib.org.uk)
  • People with Usher syndrome type III experience hearing loss and vision loss beginning somewhat later in life. (beds.ac.uk)
  • Some people with Usher syndrome type III develop vestibular abnormalities that cause problems with balance. (beds.ac.uk)
  • People with Usher syndrome type 2a are usually born with hearing loss and start to have progressive vision loss during adulthood. (globalgenes.org)
  • Many people with Usher Syndrome identify as DeafBlind. (lhblind.org)
  • The Lighthouse for the Blind, Inc. is one of the largest employers of people who are DeafBlind, many of whom have Usher Syndrome. (lhblind.org)
  • Children with Type I Usher syndrome are born profoundly deaf and have balance issues that can have an impact on the child's development. (wa.gov)
  • Patients with a hereditary syndrome may wish to seek genetic counseling before having children. (msdmanuals.com)
  • In the Usher syndrome form of the disease the retinal condition tends to be diagnosed later rather than earlier in the life of the deaf person and affected individuals may not know they have RP until they have reached young adulthood. (deafblind.co.uk)
  • If a person with Usher marries another deaf person, the latter should be tested to see if they have the condition, albeit mildly. (deafblind.co.uk)
  • Thayer Walker writes that "Bill Barkeley is a 46 year old father of 3 with Usher syndrome, a condition that has left him legally deaf and blind. (debraoakland.com)
  • Counseling Students Who Have Usher Syndrome: Teacher Tipsheet Compiled by Patricia Lago-Avery, retired counselor/professor from the National Technical Institute for the Deaf, RIT, Rochester, New York. (wa.gov)
  • Usher Syndrome is a rare genetic disorder causing individuals to go deaf and blind, and in some cases to lose vestibular control. (notionsndreams.com)
  • The Megan Foundation - Supporting deaf/blind students by allocating funds for educational scholarships, developing youth programs to build independent living skills and sponsoring travel expeditions for young adults with Usher Syndrome to explore the world before their remaining hearing and vision slips away. (notionsndreams.com)
  • Recently, a role of PDZD7 as either contributor to digenic disease or modifier of retinal disease expression in Usher syndrome has been suggested. (institut-vision.org)
  • Using an electroretinogram (ERG), a retinal response to light can be measured, which is commonly used to diagnose Usher syndrome. (amplifyeye.care)
  • caused by a CDH23 mutation may actually have Usher syndrome (described below). (nih.gov)
  • Researchers speculate that some children with apparently nonsyndromic hearing loss caused by a CDH23 mutation may actually have Usher syndrome (described below). (medlineplus.gov)
  • Our colleagues from southern Alberta were not aware of other individuals with Usher syndrome in the province (R. Brian Lowry, Alberta Children's Hospital, Calgary, Alberta, Canada, January 2012). (molvis.org)
  • The Coalition also provides information and support to individuals and families affected by Usher Syndrome. (notionsndreams.com)
  • Most individuals with Usher syndrome type I are born with severe to profound hearing loss. (beds.ac.uk)
  • This significant achievement not only raises awareness of Usher Syndrome but also serves as a testament to the power of advocacy and the impact that individuals like Dalton can have on their communities. (lhblind.org)
  • This is the reality that individuals with Usher Syndrome face. (lhblind.org)
  • If you only inherit 1 copy of an abnormal Usher syndrome gene, you won't have symptoms of the disease. (nih.gov)
  • A Cornell multidisciplinary research center that studies chronic fatigue syndrome has received a five-year, $9.5 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Disease - funding that will enable experts from disparate fields to work together on the mysterious and debilitating condition. (asbmb.org)
  • The Cornell Center for Enervating Neuroimmune Disease , established in 2017, ultimately seeks to understand the biological basis and develop a treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a disabling disorder for which there are currently no effective therapies. (asbmb.org)
  • Researchers examined the role of epigenetic modifications of the host cell gene expression in determining the pathophysiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and explored the use of vitamin D as a therapeutic agent against coronavirus disease 2019 (COVID-19). (news-medical.net)
  • Usher syndrome is a condition characterized by partial or total hearing loss and vision loss that worsens over time. (nih.gov)
  • Usher syndrome is an inherited condition that leads to hearing and vision loss that worsens over time. (genebase.com)
  • Scientists have identified three Usher syndrome types based on the degree of vision and hearing loss, the age of vision loss occurrence, and the presence of balance problems (Rogan, 2010). (topessaywriting.org)
  • Usher syndrome is a rare genetic disorder that affects both hearing and vision. (amplifyeye.care)
  • An optometrist uses various imaging tests during a vision exam to diagnose Usher syndrome. (amplifyeye.care)
  • "Even if there may not be an immediate positive outcome for me which would be a halt to my vision loss, I know by taking part in clinical trials, it is moving us forward in some capacity to understand more about Usher syndrome," Reggie. (qei.org.au)
  • Reggie was diagnosed last year with Usher syndrome, a genetic condition which results in hearing and vision loss. (qei.org.au)
  • Changing Vision, Changing Hearing: Is It Usher Syndrome? (wa.gov)
  • Usher Syndrome is a genetic disorder which includes a hearing loss at birth and a gradually developing vision impairment. (wa.gov)
  • The severity of the vision, hearing, or balance loss depends on the type of Usher Syndrome one has. (notionsndreams.com)
  • VISION for a CURE - The mission of VISION for a CURE is to raise awareness and compassion about Usher Syndrome, as well as provide funding to those that are dedicated to research to find a cure. (notionsndreams.com)
  • Usher syndrome type II is characterized by hearing loss from birth and progressive vision loss that begins in adolescence or adulthood. (beds.ac.uk)
  • Usher Syndrome Coalition is proud to be a National Alliance of the 2022 Walk4Hearing, the only nationwide event bringing attention to hearing loss and promoting the importance of hearing health. (usher-syndrome.org)
  • A portion of the funds your team raises will be directed to our organization - be sure to select "Usher Syndrome Coalition" when you register your team. (usher-syndrome.org)
  • You can support the Usher Syndrome Coalition in your Walk4Hearing. (usher-syndrome.org)
  • You can choose "Usher Syndrome Coalition" from the dropdown menu and the Usher community will benefit from your walk! (usher-syndrome.org)
  • Ninety UK-resident adults with Usher syndrome were recruited through deafblind-related charities, support groups and social groups. (figshare.com)
  • Meet adults with Usher and introduce them to the child or young adult. (wa.gov)
  • They support Facebook groups, like Awesome Moms with USH , and Young Adults Living with Usher Syndrome . (wa.gov)
  • But your children will only have symptoms if they get a second copy of the same abnormal Usher syndrome gene from their other parent. (nih.gov)
  • Understanding your carrier status will help you understand the risk of passing on Usher syndrome to your children. (genebase.com)
  • If a person with Usher marries another with the same syndrome, all their children will be expected to have the same condition. (deafblind.co.uk)
  • If a person with Usher marries a person without the condition, the children will be unlikely to have the condition, but they will be carriers. (deafblind.co.uk)
  • Bettina Kastrup Pedersen's presentation "Children 0-18 years old with Usher syndrome - Intervention" from the Deafblind International Pre-Conference on Usher Syndrome, Belfast, November 2014 is now available for download. (usher-syndrome.org)
  • Children born with Usher syndrome II have moderate to severe loss of hearing at birth. (topessaywriting.org)
  • Besides, children born with type 2 Usher syndrome have normal balance and can benefit from various hearing aids (Reiners et al. (topessaywriting.org)
  • Children born with type 3 Usher syndrome usually have normal hearing at the time of birth and almost normal balance. (topessaywriting.org)